US4203802A
(en)
*
|
1971-05-14 |
1980-05-20 |
Syva Company |
Inhibitable enzyme amplification assay
|
US3875011A
(en)
*
|
1972-11-06 |
1975-04-01 |
Syva Co |
Enzyme immunoassays with glucose-6-phosphate dehydrogenase
|
US3904367A
(en)
*
|
1973-08-15 |
1975-09-09 |
Gen Electric |
Contrast enhancement for immunological film detection
|
US4039652A
(en)
*
|
1973-10-11 |
1977-08-02 |
Miles Laboratories, Inc. |
Column method of immunoassay employing an immobilized binding partner
|
US3951748A
(en)
*
|
1974-11-11 |
1976-04-20 |
Medical Products, Inc. |
Sensitized matrix for detection of disease
|
SE388694B
(sv)
*
|
1975-01-27 |
1976-10-11 |
Kabi Ab |
Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
|
NL7501215A
(nl)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
Methode voor het aantonen en bepalen van een antigeen of antilichaam.
|
IN142734B
(es)
*
|
1975-04-28 |
1977-08-20 |
Miles Lab |
|
US4016043A
(en)
*
|
1975-09-04 |
1977-04-05 |
Akzona Incorporated |
Enzymatic immunological method for the determination of antigens and antibodies
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
US4474878A
(en)
*
|
1975-09-29 |
1984-10-02 |
Cordis Laboratories, Inc. |
Sandwich EIA for antigen associated with hepatitis
|
US4642285A
(en)
*
|
1975-09-29 |
1987-02-10 |
Diamedix Corporation |
Sandwich EIA for antigen
|
SE7610683L
(sv)
*
|
1975-09-29 |
1977-06-10 |
Cordis Corp |
Metod for bestemning av nervaron av ett antigen associerat med hepatit
|
US4116776A
(en)
*
|
1976-04-19 |
1978-09-26 |
International Radioimmune Systems, Inc. |
Diagnostic blood test and kit for detecting human chorionic gonadotropin
|
GB1572220A
(en)
*
|
1976-10-07 |
1980-07-30 |
Mochida Pharm Co Ltd |
Immunochemical process of measuring physiologically active substances
|
GB1549069A
(en)
*
|
1976-12-10 |
1979-08-01 |
Erba Farmitalia |
Enzyme linked immunoassay
|
JPS5399319A
(en)
*
|
1977-02-09 |
1978-08-30 |
Hidematsu Hirai |
Novel qualitative and quantitative detecting method and detecting body for antgenic substance
|
IT1153999B
(it)
*
|
1977-03-15 |
1987-01-21 |
Snam Progetti |
Composizione atta alla determinazione della triiodotironina e metodo diagnostico impiegante la stessa
|
IL51668A
(en)
*
|
1977-03-16 |
1981-12-31 |
Israel State |
Analytical method for the quantitative determination of immunogens and antibodies and a kit therefor
|
CA1108516A
(en)
*
|
1977-11-21 |
1981-09-08 |
Stanley E. Charm |
Antibiotic detection method
|
US4275149A
(en)
*
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
NL7804144A
(nl)
*
|
1978-04-18 |
1979-10-22 |
Akzo Nv |
Inrichting voor clorimetrische bepalingen.
|
NZ190452A
(en)
*
|
1978-05-19 |
1981-04-24 |
Becton Dickinson Co |
Solid phase assay receptor contacted with analyte and then with labeled analyte
|
JPS54170918U
(es)
*
|
1978-05-23 |
1979-12-03 |
|
|
US4273756A
(en)
*
|
1978-07-28 |
1981-06-16 |
Abbott Laboratories |
Immunoassay for class specific antibodies
|
US4292296A
(en)
*
|
1978-09-12 |
1981-09-29 |
Baxter Travenol Laboratories, Inc. |
Diagnostic method
|
US4240751A
(en)
*
|
1978-11-09 |
1980-12-23 |
Akzona Incorporated |
Method and apparatus for specific binding substances
|
US4374925A
(en)
*
|
1978-11-24 |
1983-02-22 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
US4318707A
(en)
*
|
1978-11-24 |
1982-03-09 |
Syva Company |
Macromolecular fluorescent quencher particle in specific receptor assays
|
JPS55116258A
(en)
*
|
1979-03-01 |
1980-09-06 |
Fuji Photo Film Co Ltd |
Microimmunoassay method
|
JPS55116259A
(en)
*
|
1979-03-01 |
1980-09-06 |
Fuji Photo Film Co Ltd |
Microimmunoassay method
|
US4269938A
(en)
*
|
1979-03-08 |
1981-05-26 |
Eastman Kodak Company |
Assay of peroxidatively active materials
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
GB2059421A
(en)
*
|
1979-10-03 |
1981-04-23 |
Self C H |
Assay method and reagents therefor
|
US4446231A
(en)
*
|
1979-10-03 |
1984-05-01 |
Self Colin H |
Immunoassay using an amplified cyclic detection system
|
US4347312A
(en)
*
|
1980-03-20 |
1982-08-31 |
Research Triangle Institute |
Detection of antibiotics in milk
|
JPS56143955A
(en)
*
|
1980-04-10 |
1981-11-10 |
Fujirebio Inc |
Method for diagnosis of initial infection of syphilis
|
AU543007B2
(en)
*
|
1980-04-15 |
1985-03-28 |
Technicon Instruments Corportion |
Agglutination immunoassay
|
DE3016575A1
(de)
*
|
1980-04-30 |
1981-11-05 |
Merck Patent Gmbh, 6100 Darmstadt |
Verfahren zur immunologischen bestimmung von enzymen, mittel zur durchfuehrung des verfahrens und seine verwandung
|
US6406920B1
(en)
|
1980-06-20 |
2002-06-18 |
Inverness Medical Switzerland Gmbh |
Processes and apparatus for carrying out specific binding assays
|
EP0146654A3
(en)
*
|
1980-06-20 |
1986-08-20 |
Unilever Plc |
Processes and apparatus for carrying out specific binding assays
|
NL185309C
(nl)
|
1980-07-28 |
1990-03-01 |
Akzo Nv |
Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
|
US4376110A
(en)
*
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4486530A
(en)
*
|
1980-08-04 |
1984-12-04 |
Hybritech Incorporated |
Immunometric assays using monoclonal antibodies
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
NZ199286A
(en)
*
|
1980-12-22 |
1986-05-09 |
Commw Serum Lab Commission |
A method of detecting antibodies or an antigenic or haptenic substance in a sample
|
US4517288A
(en)
*
|
1981-01-23 |
1985-05-14 |
American Hospital Supply Corp. |
Solid phase system for ligand assay
|
US4425438A
(en)
*
|
1981-03-13 |
1984-01-10 |
Bauman David S |
Assay method and device
|
GB2095258B
(en)
*
|
1981-03-19 |
1984-09-05 |
Janssen Pharmaceutica Nv |
A bright field light microscopic method of localizing tissue antigens
|
US4592995A
(en)
*
|
1981-03-30 |
1986-06-03 |
Dainippon Pharmaceutical Co., Ltd. |
Reagent for streptococcal anti-esterase assay
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
JPS57193643U
(es)
*
|
1981-06-03 |
1982-12-08 |
|
|
US4447528A
(en)
*
|
1981-08-10 |
1984-05-08 |
Corning Glass Works |
Detecting intrinsic factor blocking site antibody
|
EP0091911A4
(en)
*
|
1981-08-31 |
1984-04-06 |
Icl Scient |
IMMUNOHISTOCHEMICAL DETECTION WITH GLUCOSE OXIDASE OF ANTI-NUCLEAR ANTIBODIES.
|
US4452886A
(en)
*
|
1981-09-21 |
1984-06-05 |
Henry Robert P |
Novel photon absorbing or emitting polymers and their use as reagents in immunoassay systems
|
US4446232A
(en)
*
|
1981-10-13 |
1984-05-01 |
Liotta Lance A |
Enzyme immunoassay with two-zoned device having bound antigens
|
US4753875A
(en)
*
|
1981-11-02 |
1988-06-28 |
Ryan James W |
Method for assaying proteases with tagged proteinaceous inhibitors
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4469787A
(en)
*
|
1982-05-14 |
1984-09-04 |
Mallinckrodt Inc. |
Immunoassay involving soluble complex of second antibody and labeled binding protein
|
US4503143A
(en)
*
|
1982-08-20 |
1985-03-05 |
Btc Diagnostics Limited Partnership |
Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen
|
US4530900A
(en)
*
|
1982-09-13 |
1985-07-23 |
Seragen Diagnostics Inc. |
Soluble insoluble polymers in enzymeimmunoassay
|
FR2550799B1
(fr)
*
|
1983-08-17 |
1986-02-21 |
Commissariat Energie Atomique |
Compose marque par une enzyme, son procede de preparation et son utilisation en enzymoimmunologie
|
JPS60501570A
(ja)
*
|
1983-11-08 |
1985-09-19 |
クイデル |
迅速プランジヤ−免疫学的検定法及び装置
|
US4777240A
(en)
*
|
1984-03-08 |
1988-10-11 |
Scripps Clinic And Research Foundation |
SV40 expression vector containing HBxAg as an expression marker
|
US4645828A
(en)
|
1984-03-23 |
1987-02-24 |
Oncogen |
Platelet related growth regulator
|
US4665020A
(en)
*
|
1984-05-30 |
1987-05-12 |
United States Department Of Energy |
Flow cytometer measurement of binding assays
|
US4812396A
(en)
*
|
1984-11-05 |
1989-03-14 |
E. I. Du Pont De Nemours And Company |
Method for detecting enzymatic activity using particle agglutination
|
US4812395A
(en)
*
|
1984-11-05 |
1989-03-14 |
E. I. Du Pont De Nemours And Company |
Method for detecting enzymatic activity using particle agglutination
|
US4713347A
(en)
*
|
1985-01-14 |
1987-12-15 |
Sensor Diagnostics, Inc. |
Measurement of ligand/anti-ligand interactions using bulk conductance
|
US4824784A
(en)
*
|
1985-04-08 |
1989-04-25 |
Hygeia Sciences, Incorporated |
Chromogenic solution for immunoassay
|
US4837395A
(en)
*
|
1985-05-10 |
1989-06-06 |
Syntex (U.S.A.) Inc. |
Single step heterogeneous assay
|
US4931385A
(en)
*
|
1985-06-24 |
1990-06-05 |
Hygeia Sciences, Incorporated |
Enzyme immunoassays and immunologic reagents
|
US4868108A
(en)
*
|
1985-12-12 |
1989-09-19 |
Hygeia Sciences, Incorporated |
Multiple-antibody detection of antigen
|
CH670709A5
(es)
*
|
1986-04-24 |
1989-06-30 |
Univ Moskovsk |
|
US5039607A
(en)
*
|
1988-05-17 |
1991-08-13 |
Syntex (U.S.A.) Inc. |
Method for immunochromatographic analysis
|
US5334513A
(en)
*
|
1988-05-17 |
1994-08-02 |
Syntex (U.S.A.) Inc. |
Method for immunochromatographic analysis
|
US5102788A
(en)
*
|
1988-11-21 |
1992-04-07 |
Hygeia Sciences, Inc. |
Immunoassay including lyophilized reactant mixture
|
US5135863A
(en)
*
|
1988-12-23 |
1992-08-04 |
Syntex (U.S.A.) Inc. |
Compositions and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
WO1992020820A1
(en)
*
|
1991-05-15 |
1992-11-26 |
Vanderbilt University |
Method to determine metastatic potential of tumor cells
|
US5348867A
(en)
*
|
1991-11-15 |
1994-09-20 |
George Georgiou |
Expression of proteins on bacterial surface
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US5801005A
(en)
*
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
US5869445A
(en)
*
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
US6953573B1
(en)
|
1993-03-17 |
2005-10-11 |
University Of Washington |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
|
AU679008B2
(en)
*
|
1993-05-06 |
1997-06-19 |
Chiron Diagnostics Corporation |
Mixed luminescent conjugate test assays
|
AU2635295A
(en)
*
|
1994-06-13 |
1996-01-05 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US5698686A
(en)
|
1994-10-20 |
1997-12-16 |
Arch Development Corporation |
Yeast telomerase compositions
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5858661A
(en)
*
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5807552A
(en)
*
|
1995-08-04 |
1998-09-15 |
Board Of Regents, The University Of Texas System |
Compositions for conferring immunogenicity to a substance and uses thereof
|
US6689757B1
(en)
|
1996-02-12 |
2004-02-10 |
M.L. Laboratories Plc |
Methods for vaccination and vaccines therefor
|
US6942862B2
(en)
*
|
1996-04-01 |
2005-09-13 |
University Of Washington |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
|
WO1998001533A1
(en)
|
1996-07-08 |
1998-01-15 |
Burstein Laboratories, Inc. |
Cleavable signal element device and method
|
US20050069923A1
(en)
*
|
1996-07-08 |
2005-03-31 |
Mullis Kary Banks |
Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
|
US20050214827A1
(en)
*
|
1996-07-08 |
2005-09-29 |
Burstein Technologies, Inc. |
Assay device and method
|
US6331275B1
(en)
|
1996-07-08 |
2001-12-18 |
Burstein Technologies, Inc. |
Spatially addressable, cleavable reflective signal elements, assay device and method
|
US6342349B1
(en)
|
1996-07-08 |
2002-01-29 |
Burstein Technologies, Inc. |
Optical disk-based assay devices and methods
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
WO1999009046A1
(en)
*
|
1997-08-21 |
1999-02-25 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US6610838B1
(en)
|
1997-09-10 |
2003-08-26 |
Symbicom Aktiebolag |
P13 antigens from Borrelia
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
EP1027453A4
(en)
|
1997-10-17 |
2004-12-01 |
Univ South Florida |
METHOD FOR DIAGNOSING AND MONITORING CELLULAR IMMUNE DEFICIENCIES
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
WO2000002561A1
(en)
|
1998-07-13 |
2000-01-20 |
University Of South Florida |
Modulation of the phospholipase a2 pathway as a therapeutic
|
WO2000005582A2
(en)
*
|
1998-07-21 |
2000-02-03 |
Burstein Laboratories, Inc. |
Optical disc-based assay devices and methods
|
EP1018004B1
(en)
|
1998-07-22 |
2006-11-22 |
Syntron Bioresearch, Inc. |
Multiple analyte assay device
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
IL142094A0
(en)
*
|
1998-09-29 |
2002-03-10 |
Gamida Cell Ltd |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
AU2150900A
(en)
|
1998-11-16 |
2000-06-05 |
Board Of Regents, The University Of Texas System |
Hiv-specific t-cell induction
|
EP1147176B1
(en)
*
|
1999-02-04 |
2009-12-16 |
Pluristem Ltd. |
Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
WO2001000859A1
(en)
*
|
1999-06-25 |
2001-01-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of inducing angiogenesis by micro-organs
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7811981B2
(en)
*
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
US7167615B1
(en)
|
1999-11-05 |
2007-01-23 |
Board Of Regents, The University Of Texas System |
Resonant waveguide-grating filters and sensors and methods for making and using same
|
US7223902B1
(en)
|
1999-11-19 |
2007-05-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of producing recombinant Aspergillus niger β-glucosidase and an aroma spreading plant
|
US6544506B2
(en)
*
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
EP1252292A4
(en)
*
|
2000-01-24 |
2004-11-17 |
Univ Ramot |
PLANTS TOLERATING THE STRESS OF THE ENVIRONMENT, METHODS OF MAKING SAME FOR THIS TYPE OF PLANT AND POLYNUCLEOTIDE SEQUENCE USED THEREFOR
|
EP2316950A1
(en)
|
2000-03-27 |
2011-05-04 |
Technion Research and Development Foundation, Ltd. |
Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same
|
US20040191260A1
(en)
*
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
EP2359853B1
(en)
|
2000-08-08 |
2013-11-06 |
Technion Research and Development Foundation, Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis
|
US20030114410A1
(en)
*
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
EP1683874A3
(en)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
US7632522B2
(en)
*
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
EP1379127B1
(en)
*
|
2000-09-28 |
2013-04-17 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
AU2002211201B2
(en)
*
|
2000-11-02 |
2007-05-31 |
The National University Of Singapore |
aopB Gene, protein, homologs, fragments and variants thereof, and their use for cell surface display
|
KR100917854B1
(ko)
|
2000-11-17 |
2009-09-18 |
바스큘라 바이오제닉스 리미티드 |
내피세포 특이성을 나타내는 프로모터 및 이를 이용하는방법
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
AU2002218461B2
(en)
|
2000-11-24 |
2006-09-07 |
Vascular Biogenics Ltd |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
US20040248093A1
(en)
*
|
2000-11-27 |
2004-12-09 |
Coombs James Howard |
Magneto-optical bio-discs and systems including related methods
|
US20030003464A1
(en)
*
|
2000-11-27 |
2003-01-02 |
Phan Brigitte C. |
Dual bead assays including optical biodiscs and methods relating thereto
|
US20020172980A1
(en)
*
|
2000-11-27 |
2002-11-21 |
Phan Brigitte Chau |
Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
|
WO2002043651A2
(en)
*
|
2000-11-30 |
2002-06-06 |
Yeda Research And Development Co. Ltd. |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
EP1356298B1
(en)
|
2000-11-30 |
2011-05-18 |
Crawford Healthcare Holdings Limited |
Diagnosis of disease
|
US20020142287A1
(en)
*
|
2000-12-14 |
2002-10-03 |
Hirotaka Yamamoto |
High throughput assay to detect inhibitors of the map kinase pathway
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
WO2002060376A2
(en)
*
|
2001-01-31 |
2002-08-08 |
Tolaren |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20050202098A1
(en)
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
US7033747B2
(en)
|
2001-04-11 |
2006-04-25 |
Nagaoka & Co., Ltd |
Multi-parameter assays including analysis discs and methods relating thereto
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
EP1414838A4
(en)
*
|
2001-07-19 |
2005-12-14 |
Yissum Res Dev Co |
POLYPEPTIDES HAVING CATALYTIC ACTIVITY OF CAROTENOID ISOMERASE, NUCLEIC ACIDS ENCODING THESE POLYPEPTIDES AND APPLICATIONS THEREOF
|
CA2458640A1
(en)
|
2001-08-16 |
2003-03-06 |
Bar-Ilan University |
Diagnosis, prevention and treatment of cancer
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
CA2463816C
(en)
|
2001-10-19 |
2014-07-08 |
Vascular Biogenics Ltd. |
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
|
AUPR842501A0
(en)
*
|
2001-10-23 |
2001-11-15 |
Epipop Pty Ltd |
A method for identification and development of therapeutic agents
|
US6867005B2
(en)
|
2001-10-24 |
2005-03-15 |
Beckman Coulter, Inc. |
Method and apparatus for increasing the dynamic range and accuracy of binding assays
|
US6696254B2
(en)
|
2001-11-21 |
2004-02-24 |
Kimberly-Clark Worldwide, Inc. |
Detection and identification of enteric bacteria
|
WO2003048298A2
(en)
*
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
*
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
EP1465982A4
(en)
*
|
2002-01-25 |
2006-06-07 |
Gamida Cell Ltd |
PROCESS FOR EXPANSION OF STEM AND PRESERVATIVE CELLS AND EXPANDED CELL POPULATIONS THEREWITH OBTAINED
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
JP2005533486A
(ja)
*
|
2002-02-20 |
2005-11-10 |
ダイアックス、コープ |
Mhc−ペプチド複合体結合リガンド
|
EP3031910B1
(en)
|
2002-02-21 |
2017-08-16 |
Institute Of Virology |
Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use
|
AU2003214614B2
(en)
*
|
2002-03-18 |
2008-11-20 |
Gamida-Cell Ltd. |
Methods of inducing differentiation in ex vivo expanded stem cells
|
WO2003079967A2
(en)
*
|
2002-03-26 |
2003-10-02 |
Nanocyte Inc. |
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
|
DE60328477D1
(de)
*
|
2002-04-16 |
2009-09-03 |
Univ California |
Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
JP2005533102A
(ja)
*
|
2002-07-12 |
2005-11-04 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
微小器官によって生物学的プロセスを誘発する方法と装置
|
AU2003247143B2
(en)
|
2002-08-01 |
2009-07-16 |
Yeda Research And Development Co. Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
WO2004018698A2
(en)
|
2002-08-20 |
2004-03-04 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
US20040146949A1
(en)
*
|
2002-10-25 |
2004-07-29 |
Jun Tan |
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease
|
EP1578999B1
(en)
|
2002-10-30 |
2013-01-16 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Method for measuring non-transferrin bound iron
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
AU2003302701A1
(en)
*
|
2002-11-29 |
2004-06-23 |
Technion Research And Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
JP4676202B2
(ja)
|
2002-12-12 |
2011-04-27 |
アール.ビー.ティー (ラクト バイオ テクノロジーズ) リミテッド |
リグニンペルオキシオダーゼの製造方法ならびに皮膚および毛髪の明色化におけるその使用
|
ES2571355T3
(es)
|
2002-12-16 |
2016-05-24 |
Technion Res & Dev Foundation |
Sistema de cultivo sin células alimentadoras ni xenocontaminantes para células madre embrionarias humanas
|
WO2004058181A2
(en)
|
2002-12-20 |
2004-07-15 |
Board Of Regents, The University Of Texas System |
Vmp-like sequences of pathogenic borrelia species and strains
|
EP1587953B1
(en)
|
2003-01-02 |
2012-02-22 |
Rappaport Family Institute for Research in the Medical Sciences |
Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
|
WO2004060791A1
(en)
*
|
2003-01-07 |
2004-07-22 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures encapsulating a foreign material and method of manufacturing same
|
EP1599730A2
(en)
*
|
2003-03-03 |
2005-11-30 |
Kouyama, Yoshihisa |
Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
|
US7786071B2
(en)
|
2003-03-04 |
2010-08-31 |
Yeda Research And Development Co. Ltd. |
Pon polypeptides polynucleotides encoding same and compositions and methods utilizing same
|
EP1601759A4
(en)
*
|
2003-03-07 |
2007-02-14 |
Gamida Cell Ltd |
EXPANSION OF RENEWABLE STEM CELL POPULATIONS USING PI-3 KINASE MODULATORS
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
US7524938B2
(en)
|
2003-04-04 |
2009-04-28 |
Yeda Research And Development Co., Ltd. |
Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
|
CA2520023C
(en)
|
2003-04-08 |
2013-02-05 |
Yeda Research And Development Co. Ltd |
Stem cells having increased sensitivity to sdf-1 and methods of generating and using same
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
US20050002953A1
(en)
*
|
2003-05-06 |
2005-01-06 |
Jens Herold |
SARS-coronavirus virus-like particles and methods of use
|
CN101942449B
(zh)
|
2003-05-22 |
2014-07-02 |
伊沃基因有限公司 |
提高植物非生物胁迫耐受性和/或生物量的方法及用该方法所产生的植物
|
US7554007B2
(en)
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
US7910523B2
(en)
|
2003-05-23 |
2011-03-22 |
Board Of Regents, The University Of Texas System |
Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting AP-1 transcription factors
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
US7498428B2
(en)
*
|
2003-06-19 |
2009-03-03 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
EP1638517A4
(en)
*
|
2003-06-30 |
2010-01-06 |
Univ Tel Aviv Future Tech Dev |
PEPTIDES, ANTIBODIES AGAINST DISEASES ASSOCIATED WITH AMYLOID AND METHODS OF USE FOR THE DIAGNOSIS AND TREATMENT OF THESE DISEASES
|
AU2004257645A1
(en)
*
|
2003-07-07 |
2005-01-27 |
David H. Wagner |
Methods for predicting development of auto-immune diseases and treatment of same
|
RU2006107931A
(ru)
*
|
2003-08-14 |
2006-07-27 |
Дзе Байо Бэлэнс Корпорейшн (Us) |
Бактериальные штаммы, включающие их композиции и их пробиотическое применение
|
WO2005031362A2
(en)
|
2003-10-02 |
2005-04-07 |
Ramot At Tel Aviv University Ltd. |
Novel antibacterial agents and methods of identifying and utilizing same
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
DK1678209T3
(da)
|
2003-10-07 |
2011-06-27 |
Yeda Res & Dev |
Antistoffer mod nik, deres frembringelse samt anvendelse
|
AU2004284298A1
(en)
*
|
2003-10-23 |
2005-05-06 |
Pfizer Products Inc. |
Vaccine for periodontal disease
|
ES2346977T3
(es)
|
2003-11-04 |
2010-10-22 |
Novartis Vaccines And Diagnostics, Inc. |
Procedimiento de terapia para canceres que expresan el antigeno cd40.
|
ATE476991T1
(de)
|
2003-11-04 |
2010-08-15 |
Novartis Vaccines & Diagnostic |
Verfahren zur behandlung von soliden tumoren mit expression des cd40-zelloberflächen-antigens
|
CA2544951A1
(en)
|
2003-11-04 |
2005-05-19 |
Chiron Corporation |
Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma
|
CN1929862B
(zh)
|
2003-11-04 |
2012-02-15 |
诺华疫苗和诊断公司 |
拮抗性抗-cd40单克隆抗体治疗慢性淋巴细胞性白血病的应用
|
JP5039383B2
(ja)
|
2003-11-30 |
2012-10-03 |
イエダ リサーチ アンド ディベロップメント カンパニー リミテッド |
免疫モジュレーションのための方法および薬剤ならびに免疫モジュレーターの同定方法
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
DK1722834T3
(da)
|
2003-12-22 |
2012-10-22 |
Regentis Biomaterials Ltd |
Matrix, som omfatter naturligt forekommende tværbundet proteinskelet
|
US8007847B2
(en)
*
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
US20060147946A1
(en)
*
|
2004-01-27 |
2006-07-06 |
Pinchas Akiva |
Novel calcium channel variants and methods of use thereof
|
WO2005084699A1
(en)
|
2004-03-02 |
2005-09-15 |
Acceleron Pharma Inc. |
Alk7 and myostatin inhibitors and uses thereof
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
BRPI0511395B1
(pt)
*
|
2004-06-14 |
2019-03-06 |
Evogene Ltd. |
Construção de ácido nucléico, e, método de melhoria do rendimento da fibra de uma planta produtora de fibra
|
US8680062B2
(en)
*
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2006006172A2
(en)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
AU2005335203A1
(en)
*
|
2004-09-08 |
2007-02-15 |
The United States Of America As Represented By The Secretary Of Health And Human Services, Nih |
Compositions and methods for the detection of HIV-1/HIV-2 infection
|
WO2006030442A2
(en)
*
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
US20060095241A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
US8000900B2
(en)
|
2004-09-21 |
2011-08-16 |
Microsoft Corporation |
Association-based predictions of pathogen characteristics
|
AU2005288527B9
(en)
*
|
2004-09-29 |
2011-07-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Recombinant human T2 RNase and uses thereof
|
DE602005023332D1
(de)
|
2004-09-29 |
2010-10-14 |
Collplant Ltd |
Kollagenproduzierende pflanzen sowie verfahren zu deren erzeugung und verwendung
|
EP1809374A4
(en)
*
|
2004-10-12 |
2008-09-10 |
Closed Loop Therapies Ltd |
IMPLANTABLE METHODS AND DEVICES FOR TREATING SUPRAVENTRICULAR ARRHYTHMIAS
|
US8478535B2
(en)
|
2004-10-29 |
2013-07-02 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
EP1809765A2
(en)
*
|
2004-11-04 |
2007-07-25 |
Roche Diagnostics GmbH |
Classification of acute myeloid leukemia
|
US7842794B2
(en)
|
2004-12-17 |
2010-11-30 |
Roche Molecular Systems, Inc. |
Reagents and methods for detecting Neisseria gonorrhoeae
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
EP1872604A4
(en)
*
|
2005-01-16 |
2010-01-20 |
Zlango Ltd |
COMMUNICATION NETWORK SYSTEM AND METHODS OF USE
|
JP2008527563A
(ja)
*
|
2005-01-16 |
2008-07-24 |
ズランゴー リミテッド |
アイコニック通信
|
WO2007080558A2
(en)
*
|
2006-01-16 |
2007-07-19 |
Zlango Ltd. |
Communications network system and methods for using same
|
ES2562406T3
(es)
|
2005-01-31 |
2016-03-04 |
Realbio Technologies Ltd. |
Dispositivo capilar de flujo lateral de reacción multietapa
|
CA2597699C
(en)
|
2005-02-17 |
2012-07-31 |
Hadasit Medical Research Services And Development Ltd. |
Bisphosphonates for treating endometriosis
|
US8216801B2
(en)
|
2005-02-25 |
2012-07-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani Center |
Methods for treating inflammatory disorders
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
EP1874334A4
(en)
*
|
2005-04-15 |
2011-03-30 |
Vascular Biogenics Ltd |
COMPOSITIONS WITH BETA 2-GLYCOPROTEIN I-PEPTIDES FOR THE PREVENTION AND / OR TREATMENT OF VASCULAR DISEASES
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
PT1889065E
(pt)
|
2005-05-18 |
2013-09-27 |
Novartis Ag |
Métodos para o diagnóstico e tratamento de doenças tendo uma componente autoimune e/ou inflamatória
|
WO2006126208A2
(en)
|
2005-05-26 |
2006-11-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
CN101243178A
(zh)
|
2005-06-16 |
2008-08-13 |
特拉维夫大学拉莫特有限公司 |
用于治疗cns疾病的分离细胞和包含这种细胞的细胞群
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
US20060292559A1
(en)
*
|
2005-06-23 |
2006-12-28 |
Beckman Coulter, Inc. |
Cell-based microarrays, and methods for their preparation and use
|
WO2007007317A1
(en)
|
2005-07-07 |
2007-01-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acid agents for downregulating h19, and methods of using same
|
JP5086254B2
(ja)
|
2005-07-07 |
2012-11-28 |
フルクルム エスピー リミテッド |
Sp1ポリペプチド、変性sp1ポリペプチドおよびそれらの使用
|
AU2006271181B2
(en)
|
2005-07-18 |
2012-07-12 |
Protalix Ltd. |
Mucosal or enteral administration of biologically active macromolecules
|
CA2616766A1
(en)
|
2005-07-26 |
2007-02-01 |
University Of Medicine And Dentistry Of New Jersey |
Antibody profiles characteristic of tuberculosis state
|
CA2615460A1
(en)
*
|
2005-08-08 |
2007-02-15 |
Onconon, Llc |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
US8916147B2
(en)
|
2005-08-24 |
2014-12-23 |
Yeda Research and Devolpment Co. Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
EP1962719A4
(en)
|
2005-08-29 |
2011-05-04 |
Technion Res And Dev Of Foundation Ltd |
MEDIA FOR BREEDING STEM CELLS
|
US8034914B2
(en)
*
|
2005-09-22 |
2011-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
CN101505587A
(zh)
|
2005-10-24 |
2009-08-12 |
伊沃基因有限公司 |
分离的多肽、编码其的多核苷酸、表达其的转基因植物和使用其的方法
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
WO2007063545A2
(en)
|
2005-11-29 |
2007-06-07 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
US8775526B2
(en)
|
2006-01-16 |
2014-07-08 |
Zlango Ltd. |
Iconic communication
|
EP2368570A3
(en)
|
2006-01-18 |
2012-05-02 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
WO2007092252A2
(en)
*
|
2006-02-03 |
2007-08-16 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
WO2007091254A1
(en)
|
2006-02-06 |
2007-08-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods and kit for diagnosing t1dm
|
AU2007224386B2
(en)
|
2006-03-06 |
2013-12-19 |
Zetiq Technologies Ltd. |
Methods and compositions for identifying a cell phenotype
|
EP2626417B1
(en)
|
2006-03-23 |
2015-09-02 |
Pluristem Ltd. |
Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
|
EP2004858A4
(en)
|
2006-03-28 |
2009-12-09 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
METHOD AND KITS FOR DETERMINING AN INVESTMENT TO WARFARINE RESISTANCE
|
KR20090029184A
(ko)
*
|
2006-04-07 |
2009-03-20 |
더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
항체 조성물 및 신생물성 질병의 치료 방법
|
MEP39508A
(en)
|
2006-04-21 |
2011-02-10 |
Novartis Ag |
Antagonist anti-cd40 antibody pharmaceutical compositions
|
JP5225266B2
(ja)
*
|
2006-05-19 |
2013-07-03 |
テバ ファーマシューティカル インダストリーズ リミティド |
融合タンパク質、その使用、およびその製造方法
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
EP2046109A4
(en)
|
2006-07-20 |
2010-01-06 |
Yeda Res & Dev |
PHOTOSYNTHETIC ORGANISMS, COMPOSITIONS AND METHODS FOR GENERATING THESE ORGANISMS
|
EP2064319B1
(en)
|
2006-08-28 |
2017-02-22 |
Yeda Research and Development Co. Ltd. |
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns
|
AU2007292369A1
(en)
*
|
2006-09-08 |
2008-03-13 |
Wisconsin Alumni Research Foundation |
Assay for antibodies to Mycobacterium paratuberculosis
|
CN101595251B
(zh)
|
2006-10-05 |
2014-06-11 |
技术研究及发展基金有限公司 |
微管及其制备方法
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
AU2007335706B2
(en)
|
2006-12-20 |
2013-03-28 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
GB0700133D0
(en)
|
2007-01-04 |
2007-02-14 |
Humabs Llc |
Human cytomegalovirus neutralising antibodies and use thereof
|
US7928083B2
(en)
*
|
2007-01-16 |
2011-04-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
H19 silencing nucleic acid agents for treating rheumatoid arthritis
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
WO2008093341A2
(en)
|
2007-01-31 |
2008-08-07 |
Technion Research & Development Foundation Ltd. |
Electrospun scaffolds and methods of generating and using same
|
EP2125050B1
(en)
|
2007-02-01 |
2014-07-30 |
Technion Research & Development Foundation Ltd. |
Albumin fibers and fabrics and methods of generating and using same
|
TWI422594B
(zh)
|
2007-02-02 |
2014-01-11 |
Baylor Res Inst |
經由樹狀細胞去唾液酸糖蛋白受體(dc-asgpr)接合抗原呈現細胞之藥劑
|
JP5377330B2
(ja)
|
2007-02-02 |
2013-12-25 |
ベイラー リサーチ インスティテュート |
抗原提示細胞上に発現されたdcirへの抗原のターゲティングに基づくワクチン
|
MX2009008143A
(es)
|
2007-02-02 |
2009-10-20 |
Baylor Res Inst |
Antienos multivariables acomplejados con anticuerpo monoclonal humanizado de apuntamiento.
|
EP3489260B1
(en)
*
|
2007-02-23 |
2020-12-02 |
Baylor Research Institute |
Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized ldl receptor-1 (lox-1)
|
KR20090114466A
(ko)
|
2007-02-23 |
2009-11-03 |
베일러 리서치 인스티튜트 |
덱틴-1을 통한 사람 항원제시세포 활성화의 치료학적 적용
|
CN101668777A
(zh)
*
|
2007-02-23 |
2010-03-10 |
贝勒研究院 |
通过clec-6激活人抗原呈递细胞
|
WO2008104979A2
(en)
|
2007-02-28 |
2008-09-04 |
Yeda Research And Development Co. Ltd. |
Nuclear targeting sequences
|
CA2682093A1
(en)
|
2007-03-29 |
2008-10-09 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
CN101702920B
(zh)
|
2007-04-02 |
2013-03-13 |
特拉维夫大学拉莫特有限公司 |
癌细胞的检测方法及其在诊断和监测疾病治疗中的应用
|
BR122020016899B1
(pt)
|
2007-04-09 |
2021-06-22 |
Evogene Ltd |
Método para aumentar o teor de óleo, taxa de crescimento, biomassa, vigor e/ou rendimento de uma planta, e, construção de ácido nucleico isolado
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2008129548A2
(en)
*
|
2007-04-23 |
2008-10-30 |
Segev Laboratories Limited |
A system for delivering therapeutic agents into living cells and cells nuclei
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
US8338113B2
(en)
|
2007-05-01 |
2012-12-25 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods for detecting fetal cells in the maternal blood
|
WO2008136774A1
(en)
|
2007-05-03 |
2008-11-13 |
Agency For Science, Technology And Research |
Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
|
BRPI0810343B1
(pt)
|
2007-05-07 |
2021-03-30 |
Protalix Ltd |
Dispositivo descartável para o cultivo e colheita de tecidos vegetais e/ou células, método de cultivo e colheita de um tecido vegetal e/ou células vegetais em um volume maior do que 400 litros e sistema de cultivo da célula vegetal
|
EP2500428A3
(en)
|
2007-07-11 |
2012-12-26 |
Yeda Research and Development Co. Ltd. |
Nucleic acid construct systems capable of diagnosing or treating a cell state
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
JP2010533705A
(ja)
|
2007-07-15 |
2010-10-28 |
ヒルマン,イチャク |
抗菌ペプチドまたはその阻害剤を用いた疾病治療
|
EP2910638B1
(en)
|
2007-07-24 |
2018-05-30 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same
|
CN105330743B
(zh)
|
2007-08-02 |
2019-05-28 |
吉利德生物制剂公司 |
Lox和loxl2抑制剂及其应用
|
CN102083455B
(zh)
|
2007-08-15 |
2015-01-07 |
耶达研究及发展有限公司 |
Mmp-9的调节剂及其用途
|
US8741315B2
(en)
|
2007-09-12 |
2014-06-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating tumors in immune-privileged sites
|
WO2009072001A2
(en)
*
|
2007-09-12 |
2009-06-11 |
Aurelium Biopharma Inc. |
Slc9a3r1 directed diagnostics for neoplastic disease
|
AU2008300185B2
(en)
|
2007-09-19 |
2013-09-05 |
Pluristem Ltd. |
Adherent cells from adipose or placenta tissues and use thereof in therapy
|
EP2781223B1
(en)
|
2007-10-19 |
2017-02-22 |
Rappaport Family Institute for Research in the Medical Sciences |
Compositions comprising semaphorins for use in the treatment of cancer
|
WO2009059328A2
(en)
*
|
2007-11-02 |
2009-05-07 |
The Johns Hopkins University |
Multi- component l2 vaccine for prevention of human papillomavirus infection
|
WO2009069123A2
(en)
|
2007-11-26 |
2009-06-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions comprising fibrous polypeptides and polysaccharides
|
CN101977928B
(zh)
|
2007-12-27 |
2014-12-10 |
伊沃基因有限公司 |
用于改进植物的水分利用效率、肥料利用效率、生物/非生物胁迫耐受性、产量和生物量的分离多肽、多核苷酸
|
US20090233295A1
(en)
*
|
2008-01-29 |
2009-09-17 |
Elias Georges |
Trim59 directed diagnostics for neoplastic disease
|
WO2009095925A2
(en)
*
|
2008-01-31 |
2009-08-06 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
US9464368B2
(en)
|
2008-02-21 |
2016-10-11 |
Technion Research & Development Foundation Ltd. |
Methods of attaching a molecule-of-interest to a microtube
|
US8153383B2
(en)
*
|
2008-03-18 |
2012-04-10 |
Wisconsin Alumni Research Foundation |
Mycobacterial culture screening test for Mycobacterium avium complex bacteria
|
WO2009125395A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Technion Research & Development Foundation Ltd. |
Anti influenza antibodies and uses thereof
|
US8747855B2
(en)
*
|
2008-04-09 |
2014-06-10 |
Technion Research & Development Foundation Limited |
Anti human immunodeficiency antibodies and uses thereof
|
WO2009125381A1
(en)
*
|
2008-04-10 |
2009-10-15 |
Objet Geometries Ltd. |
System and method for three dimensional model printing
|
EP2288376B1
(en)
|
2008-04-18 |
2016-01-13 |
Collplant Ltd. |
Methods of generating and using procollagen
|
EP2268129B1
(en)
|
2008-04-21 |
2015-06-17 |
Danziger Innovations Ltd. |
Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
|
SG176464A1
(en)
|
2008-05-09 |
2011-12-29 |
Agency Science Tech & Res |
Diagnosis and treatment of kawasaki disease
|
AU2009250806B2
(en)
*
|
2008-05-22 |
2015-04-16 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility
|
US9393273B2
(en)
|
2008-05-27 |
2016-07-19 |
Pluristem Ltd. |
Methods of treating inflammatory colon diseases
|
DK2620493T3
(da)
|
2008-05-28 |
2019-07-01 |
Univ Ramot |
Mesenkymale stamceller til behandling af CNS-sygdomme
|
CN102076415B
(zh)
|
2008-06-29 |
2015-06-24 |
瑞尔比奥技术有限公司 |
尤其可用作生物测定过程中的捕捉装置的液体转移装置
|
ES2654543T3
(es)
|
2008-07-16 |
2018-02-14 |
Institute For Research In Biomedicine |
Anticuerpos neutralizantes del citomegalovirus humano y uso de los mismos
|
EP3388450B1
(en)
|
2008-07-16 |
2021-07-07 |
Baylor Research Institute |
Hiv vaccine based on targeting maximized gag and nef to dendritic cells
|
KR20150002895A
(ko)
|
2008-07-16 |
2015-01-07 |
인스티튜트 포 리서치 인 바이오메드슨 |
인간 사이토메갈바이러스 중화 항체 및 이의 용도
|
WO2010010466A2
(en)
*
|
2008-07-25 |
2010-01-28 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
CA2731521C
(en)
|
2008-08-08 |
2018-04-10 |
Genisphere, Llc |
Long-acting dna dendrimers and methods thereof
|
JP5756014B2
(ja)
|
2008-08-08 |
2015-07-29 |
エイジェンシー・フォー・サイエンス,テクノロジー・アンド・リサーチ(エイ・スター) |
がんの診断および治療のためのvhz
|
AU2009283785B2
(en)
|
2008-08-18 |
2016-01-28 |
Evogene Ltd. |
Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants
|
RU2539786C2
(ru)
|
2008-09-02 |
2015-01-27 |
Плуристем Лтд. |
Выращенные в прикрепленной к субстрату культуре клетки из ткани плаценты и их использование при лечении
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
EP2326340A4
(en)
|
2008-09-11 |
2013-01-23 |
Univ Ben Gurion |
COMPOSITIONS AND METHODS FOR TREATING PNEUMOCOCCAL INFECTIONS
|
CN107595889A
(zh)
|
2008-09-12 |
2018-01-19 |
克里奥普拉斯低温生物有限公司 |
缺血性组织的细胞疗法
|
SG10201504623VA
(en)
|
2008-09-24 |
2015-07-30 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
EP2342356A4
(en)
|
2008-09-29 |
2012-11-21 |
Univ Ben Gurion |
AMYLOID BETA PEPTIDASES AND METHOD OF USE THEREOF
|
EP2341929B1
(en)
|
2008-10-06 |
2017-01-25 |
University Of Chicago |
Compositions and methods related to bacterial emp proteins
|
CA2736350C
(en)
|
2008-10-30 |
2021-06-22 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
WO2010055525A1
(en)
|
2008-11-17 |
2010-05-20 |
Technion Research & Development Foundation Ltd. |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(en)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A cd44vra antibody and diagnostic and therapeutic methods using same
|
WO2010061383A1
(en)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
A method of in-situ enrichment of foods with fructan
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
WO2010064247A1
(en)
|
2008-12-03 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
ES2554765T3
(es)
|
2008-12-05 |
2015-12-23 |
Yeda Research And Development Co. Ltd. |
miRNA-9 o miRNA-9* para uso en el tratamiento de ELA
|
WO2010071610A1
(en)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Severe chikungunya biomarkers
|
MX340023B
(es)
|
2008-12-29 |
2016-06-22 |
Evogene Ltd |
Polinucleotidos, polipeptidos codificados, y metodos para utilizarlos para aumentar la tolerancia al estres abiotico, biomasa y/o rendimiento en plantas que los expresan.
|
WO2010076788A2
(en)
|
2008-12-29 |
2010-07-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection
|
WO2010076642A1
(en)
|
2008-12-29 |
2010-07-08 |
Tel Hashomer Medical Research, Infrastructure And Services Ltd |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
US8455263B2
(en)
|
2008-12-30 |
2013-06-04 |
Jin Po Lee |
Quantitative analyte assay device and method
|
WO2010076794A1
(en)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Method of denitrifying brine and systems capable of same
|
WO2010080769A2
(en)
|
2009-01-06 |
2010-07-15 |
Arresto Biosciences, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
EP2391377A2
(en)
|
2009-02-02 |
2011-12-07 |
Ramot at Tel-Aviv University Ltd. |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
WO2010089707A1
(en)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
|
EP2465920B1
(en)
|
2009-02-26 |
2017-04-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Isolated populations of renal stem cells and methods of isolating and using same
|
DK3460062T3
(da)
|
2009-03-02 |
2021-07-12 |
Evogene Ltd |
Isolerede polynukleotider og polypeptider og fremgangsmåde til anvendelse deraf til øgning af planters udbytte og/eller landbrugsmæssige egenskaber
|
ES2564265T3
(es)
|
2009-03-09 |
2016-03-21 |
Ramot At Tel-Aviv University Ltd. |
Composiciones para prevención y tratamiento de enfermedades neurodegenerativas
|
WO2010103517A1
(en)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Soluble compositions for the treatment of cxcr3-ligand associated diseases
|
DK2414542T3
(da)
|
2009-03-30 |
2017-11-27 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Fremgangsmåder til forudsigelse af klinisk forløb for og behandling af multipel sklerose
|
EP2344179A1
(en)
|
2009-04-01 |
2011-07-20 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
A method of regulating proliferation and differentiation of keratinocyes
|
WO2011127032A1
(en)
|
2010-04-05 |
2011-10-13 |
University Of Chicago |
Compositions and methods related to protein a (spa) antibodies as an enhancer of immune response
|
SI3281947T1
(sl)
|
2009-04-03 |
2020-07-31 |
The University Of Chicago |
Sestave in metode v zvezi z variantami proteina A (SPA)
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
LT2990421T
(lt)
|
2009-04-30 |
2018-04-25 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anti-ceacam1 antikūnai ir jų panaudojimo būdai
|
CN102576024B
(zh)
|
2009-05-19 |
2016-10-26 |
泽蒂克科技有限公司 |
宫颈癌细胞和/或组织的鉴别染色的试剂盒和方法
|
EP2433132B1
(en)
|
2009-05-21 |
2018-02-21 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Compositions and methods for the detection of hiv-1/hiv-2 infection
|
WO2010137017A2
(en)
|
2009-05-27 |
2010-12-02 |
Yeda Research And Development Co. Ltd. |
Proteasome inhibitors and uses thereof
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
WO2010137013A1
(en)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Crystallized photosystem i units from the pea plant and their use in solid state devices
|
EP2435078A1
(en)
|
2009-05-28 |
2012-04-04 |
Yeda Research and Development Co. Ltd. |
Methods of treating inflammation
|
AU2010258264B2
(en)
|
2009-06-10 |
2016-01-28 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
CA2765779A1
(en)
|
2009-06-24 |
2010-12-29 |
Fund For Medical Research Development Of Infrastructure And Health Servi Ces - At Rambam Medical Center |
Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
CA2768725A1
(en)
|
2009-07-21 |
2011-01-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
A method of diagnosing cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
US20120148546A1
(en)
|
2009-08-17 |
2012-06-14 |
Technion Research & Development Foundation Ltd. |
Pericyte progenitor cells and methods of generating and using same
|
MX2012002189A
(es)
|
2009-08-21 |
2012-03-16 |
Beeologics Inc |
Prevencion y cura de las enfermedades de los insectos beneficiosos a traves de moleculas.
|
RU2015124151A
(ru)
*
|
2009-08-21 |
2015-12-27 |
Джилид Байолоджикс, Инк. |
Способы и композиции для лечения фиброзных заболеваний легких
|
SG178845A1
(en)
|
2009-08-21 |
2012-04-27 |
Gilead Biologics Inc |
Catalytic domains from lysyl oxidase and loxl2
|
US20110076272A1
(en)
*
|
2009-08-21 |
2011-03-31 |
Victoria Smith |
Therapeutic methods and compositions
|
US20110044907A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Derek Marshall |
In vivo screening assays
|
AU2010284000A1
(en)
*
|
2009-08-21 |
2012-03-22 |
Gilead Biologics, Inc. |
In vitro screening assays
|
US9642817B2
(en)
|
2009-08-27 |
2017-05-09 |
Technion Research & Development Foundation Limited |
Liposomal compositions and uses of same
|
WO2011030332A2
(en)
|
2009-09-08 |
2011-03-17 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
WO2011030336A1
(en)
|
2009-09-08 |
2011-03-17 |
Ramot At Tel-Aviv University Ltd. |
Methods of diagnosing amyotrophic lateral sclerosis (als)
|
WO2011030329A1
(en)
|
2009-09-10 |
2011-03-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
EP2478093A2
(en)
|
2009-09-17 |
2012-07-25 |
Yeda Research and Development Co. Ltd. |
Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
CN102498127B
(zh)
|
2009-09-17 |
2015-02-25 |
雷蒙特亚特特拉维夫大学有限公司 |
用于治疗氧化应激相关障碍的肽类
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
CN105368836A
(zh)
|
2009-10-14 |
2016-03-02 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
用于控制蜂中的瓦螨的组合物
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
CA2777663A1
(en)
|
2009-10-16 |
2011-04-21 |
University Of Medicine And Dentistry Of New Jersey |
Method for treating chronic nerve tissue injury using a cell therapy strategy
|
US9476060B2
(en)
|
2009-10-21 |
2016-10-25 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
WO2011058555A1
(en)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
A method of editing dna in a cell and constructs capable of same
|
EP3633025B1
(en)
|
2009-11-12 |
2022-09-14 |
Technion Research & Development Foundation Ltd. |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
EP2498806B1
(en)
|
2009-11-12 |
2014-12-31 |
Ramot at Tel-Aviv University Ltd. |
Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
|
US20120230974A1
(en)
|
2009-11-17 |
2012-09-13 |
Protalix Ltd |
Alkaline alpha galactosidase for the treatment of fabry disease
|
US20130183326A9
(en)
|
2009-11-20 |
2013-07-18 |
St. Jude Children's Research Hospital |
Methods and compositions for modulating the activity of the interleukin-35 receptor complex
|
US20120273993A1
(en)
|
2009-11-24 |
2012-11-01 |
Collplant Ltd. |
Method of generating collagen fibers
|
CN102639692B
(zh)
|
2009-11-30 |
2015-02-04 |
普拉里斯坦有限公司 |
来源于胎盘的贴壁细胞及其在疾病治疗中的应用
|
WO2011067745A2
(en)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions and methods for enhancing plants resistance to abiotic stress
|
WO2011072091A1
(en)
|
2009-12-09 |
2011-06-16 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the cns
|
EP3056569A3
(en)
|
2009-12-28 |
2016-10-19 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
WO2011080740A1
(en)
|
2009-12-29 |
2011-07-07 |
Gamida-Cell Ltd. |
Methods for enhancing natural killer cell proliferation and activity
|
AU2011204405B2
(en)
|
2010-01-05 |
2015-06-18 |
Vascular Biogenics Ltd. |
Methods for use of a specific anti-angiogenic adenoviral agent
|
US20130052165A1
(en)
|
2010-01-12 |
2013-02-28 |
Livnat Bangio |
Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby
|
CN102822202B
(zh)
|
2010-01-27 |
2015-07-22 |
耶达研究及发展有限公司 |
抑制金属蛋白的抗体
|
WO2011097513A1
(en)
|
2010-02-04 |
2011-08-11 |
Gilead Biologics, Inc |
Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
|
WO2011099006A2
(en)
|
2010-02-11 |
2011-08-18 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
EP2538961B1
(en)
|
2010-02-24 |
2016-10-12 |
Ben Gurion University Of The Negev Research And Development Authority |
Inhibition of necrosis
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
WO2011107994A1
(en)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Methods of measuring protein stability
|
US9267142B2
(en)
|
2010-03-08 |
2016-02-23 |
Yeda Research And Development Co. Ltd. |
Recombinant protein production in heterologous systems
|
ES2809679T3
(es)
|
2010-03-08 |
2021-03-05 |
Monsanto Technology Llc |
Moléculas polinucleotídicas para la regulación génica en plantas
|
CN102918159A
(zh)
|
2010-03-11 |
2013-02-06 |
雅各布·埃德尔 |
产生氢的方法
|
EP2556085A2
(en)
|
2010-04-05 |
2013-02-13 |
Bar-Ilan University |
Protease-activatable pore-forming polypeptides
|
WO2011128897A1
(en)
|
2010-04-12 |
2011-10-20 |
Technion Research & Development Foundation Ltd. |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
WO2011128895A2
(en)
|
2010-04-12 |
2011-10-20 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase of a red microalga and uses thereof
|
IN2012MN02247A
(es)
|
2010-04-18 |
2015-06-12 |
Yeda Res & Dev |
|
WO2011135527A2
(en)
|
2010-04-28 |
2011-11-03 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
US9352000B2
(en)
|
2010-05-05 |
2016-05-31 |
Rappaport Family Institute For Research In The Medical Sciences |
Use of CCL1 in therapy
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
WO2011141914A1
(en)
|
2010-05-13 |
2011-11-17 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Isolated populations of adult renal cells and methods of isolating and using same
|
CN103037891A
(zh)
|
2010-06-03 |
2013-04-10 |
雷蒙特亚特特拉维夫大学有限公司 |
治疗糖尿病的方法和能够治疗糖尿病的组合物
|
MX2012014284A
(es)
|
2010-06-07 |
2013-04-29 |
Osnat Ashur-Fabian |
Metodos y kits para diagnosticar afecciones relacionadas con hipoxia.
|
US9187787B2
(en)
|
2010-06-16 |
2015-11-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of diagnosing and treating cancer
|
WO2011158242A2
(en)
|
2010-06-16 |
2011-12-22 |
Futuragene Israel Ltd. |
Pest -resistant plants containing a combination of a spider toxin and a chitinase
|
EP2588120B1
(en)
|
2010-07-02 |
2017-11-15 |
The University of Chicago |
Compositions and methods related to protein a (spa) variants
|
ES2817780T3
(es)
|
2010-07-12 |
2021-04-08 |
The State Of Israel Ministry Of Agriculture And Rural Development Agricultural Res Organization A R |
Polinucleótidos aislados y métodos y plantas que usan los mismos para regular la acidez de las plantas
|
BR112013000985A2
(pt)
|
2010-07-15 |
2017-09-05 |
Technion Res & Dev Foundation |
Entidades isoladas de alta afinidade com especificidade semelhante à do receptor de célula t em relação a complexos nativos de mhc classe ii e peptídeos autoantigênicos de descarboxilase do ácido glutâmico (gad)
|
BR112013000984A2
(pt)
|
2010-07-15 |
2017-10-03 |
Technion Res & Dev Foundation |
Estrutura de ácido nucleico para o aumento da tolerância ao estresse abiótico em plantas
|
US20130189284A1
(en)
|
2010-07-15 |
2013-07-25 |
Technion Research & Development Foundation Ltd. |
Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
|
EP2595637B1
(en)
|
2010-07-22 |
2017-11-01 |
Cellect Biotherapeutics Ltd. |
Regulatory immune cells with enhanced targeted cell death effect
|
WO2012014205A1
(en)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
JP2013535966A
(ja)
|
2010-07-27 |
2013-09-19 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
引き抜かれた毛包由来のケラチン生成細胞から誘導多能性幹細胞を生成させる方法
|
US20130130311A1
(en)
|
2010-07-27 |
2013-05-23 |
Yeda Research And Development Co., Ltd. |
Methods and systems for assessing clonality of cell cultures
|
US8901074B2
(en)
|
2010-08-04 |
2014-12-02 |
Ramot At Tel-Aviv University |
Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
|
EP2606122A1
(en)
|
2010-08-22 |
2013-06-26 |
Ramot at Tel Aviv University, Ltd. |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(en)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of improving transplantation using sdf-1alpha
|
US10457954B2
(en)
|
2010-08-30 |
2019-10-29 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
US20130164288A1
(en)
|
2010-09-07 |
2013-06-27 |
Protalix Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
WO2012032510A1
(en)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Primers for amplifying dna and methods of selecting same
|
US10214722B2
(en)
|
2010-09-07 |
2019-02-26 |
Technion Research & Development Foundation Limited |
Methods for expanding and maintaining human pluripotent stem cells (PSCs) in an undifferentiated state in a single cell suspension culture
|
WO2012032519A2
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing parkinson's disease
|
ES2589678T3
(es)
|
2010-09-08 |
2016-11-15 |
Yeda Research And Development Co. Ltd. |
Uso de linfocitos T de memoria central anti-terceros para el tratamiento anti-leucemia/linfoma
|
SG188471A1
(en)
|
2010-09-08 |
2013-04-30 |
Yeda Res & Dev |
An immunosuppressive drug combination for a stable and long term engraftment
|
WO2012034067A1
(en)
|
2010-09-09 |
2012-03-15 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
EP2616539A1
(en)
|
2010-09-15 |
2013-07-24 |
Ramot at Tel-Aviv University Ltd. |
Methods of expanding and redifferentiating islet beta cells
|
WO2012038956A1
(en)
|
2010-09-20 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
EP2627766B1
(en)
|
2010-10-17 |
2016-05-25 |
Yeda Research and Development Co. Ltd. |
Methods and compositions for the treatment of insulin-associated medical conditions
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
WO2012056452A2
(en)
|
2010-10-27 |
2012-05-03 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
WO2012056455A1
(en)
|
2010-10-28 |
2012-05-03 |
Yeda Research And Development Co. Ltd. |
Methods of generating antibodies to metalloenzymes
|
AR083708A1
(es)
|
2010-11-03 |
2013-03-13 |
Yissum Res Dev Co |
Plantas transgenicas con rendimientos de sacarificacion altos y metodos para generarlas
|
WO2012059925A2
(en)
|
2010-11-04 |
2012-05-10 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-coa: diacylglycerol acyltransferase 1-like gene (ptdgat1) and uses thereof
|
TW201225972A
(en)
|
2010-11-15 |
2012-07-01 |
Univ Ramot |
Dipeptide analogs for treating conditions associated with amyloid fibril formation
|
EP2640404B1
(en)
|
2010-11-17 |
2017-02-22 |
Ben Gurion University of The Negev Research and Development Authority |
T-cell therapy to neurodegenerative diseases
|
WO2012075111A1
(en)
|
2010-11-30 |
2012-06-07 |
Novartis Ag |
Uses of anti-cd40 antibodies in combination therapy for b cell-related cancers
|
EP2646543A4
(en)
|
2010-12-02 |
2014-09-03 |
Technion Res & Dev Foundation |
METHOD FOR GENERATING CORNEAL CELLS AND CELL POPULATIONS COMPRISING THE SAME
|
EP2463382A1
(en)
|
2010-12-07 |
2012-06-13 |
Enterologics, Inc. |
Method for identifying E. Coli M-17
|
US9404087B2
(en)
|
2010-12-15 |
2016-08-02 |
Kadimastem Ltd. |
Insulin producing cells derived from pluripotent stem cells
|
MX344728B
(es)
|
2010-12-22 |
2017-01-05 |
Evogene Ltd |
Polinucleótidos y polipéptidos aislados, y métodos para utilizarlos para aumentar la tolerancia al estrés abiótico, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o eficacia en el uso de nitrógeno de las plantas.
|
KR101947126B1
(ko)
|
2010-12-28 |
2019-02-13 |
카메디스 리미티드 |
감염의 치료 및 예방을 위한 식물 추출물
|
LT3272861T
(lt)
|
2011-01-20 |
2020-03-25 |
Protalix Ltd. |
Alfa-galaktozidazės kompozicijos
|
WO2012104851A1
(en)
|
2011-01-31 |
2012-08-09 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
US20130330349A1
(en)
|
2011-02-23 |
2013-12-12 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
EP2492279A1
(en)
|
2011-02-25 |
2012-08-29 |
Laboratorios Del. Dr. Esteve, S.A. |
Rapid immunogen selection method using lentiviral display
|
BR112013022331B1
(pt)
|
2011-03-02 |
2021-01-26 |
Futuragene Israel Ltd. |
vetor de expressão de ácido nucleico, e, método para gerar uma planta que compreende resistência intensificada a um patógeno bacteriano
|
US9365828B2
(en)
|
2011-03-03 |
2016-06-14 |
Ramot At Tel-Aviv University Ltd. |
Genetically modified muscle cells which express neurotrophic factors
|
CA2829110C
(en)
|
2011-03-06 |
2019-01-15 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
WO2012120518A1
(en)
|
2011-03-08 |
2012-09-13 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (pku)
|
EP2685976B1
(en)
|
2011-03-17 |
2017-12-27 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
KR20140019385A
(ko)
|
2011-03-17 |
2014-02-14 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
이중특이성 및 단일특이성, 비대칭성 항체 및 이의 제조방법
|
KR101835917B1
(ko)
|
2011-03-22 |
2018-03-07 |
플루리스템 리미티드 |
방사선 또는 화학적 손상을 치료하는 방법들
|
WO2012127475A1
(en)
|
2011-03-24 |
2012-09-27 |
Neurim Pharmaceuticals (1991) Ltd. |
Neuroprotective peptides
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
WO2012137202A1
(en)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
|
ES2627154T3
(es)
|
2011-04-06 |
2017-07-26 |
Ramot At Tel-Aviv University Ltd. |
Métodos de seguimiento y análisis de perfiles de actividad metabólica, usos diagnósticos y terapéuticos de los mismos
|
WO2012142164A1
(en)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
|
WO2012140519A2
(en)
|
2011-04-15 |
2012-10-18 |
Pluristem Ltd. |
Methods and systems for harvesting cells
|
CA3137663A1
(en)
|
2011-05-03 |
2012-11-08 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
WO2012150600A2
(en)
|
2011-05-04 |
2012-11-08 |
Ramot At Tel-Aviv University Ltd. |
Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
WO2012153333A1
(en)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Regeneration and repair of mesenchymal tissue using amelogenin
|
WO2012153336A2
(en)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Methods and device for lightening skin complexion
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
WO2012160526A2
(en)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations of microorganism comprising particles and uses of same
|
WO2012160563A2
(en)
|
2011-05-23 |
2012-11-29 |
Yeda Research And Development Co. Ltd. |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
SG195190A1
(en)
|
2011-05-31 |
2013-12-30 |
Hutchison Biofilm Medical Solutions Ltd |
Dispersion and detachment of cell aggregates
|
WO2012164565A1
(en)
|
2011-06-01 |
2012-12-06 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
ES2670596T3
(es)
|
2011-06-14 |
2018-05-31 |
Yeda Research And Development Co. Ltd. |
Terapia de combinación para prevenir la formación del DCIS y la progresión hasta cáncer de mama
|
CN103906428A
(zh)
|
2011-06-23 |
2014-07-02 |
凯伊玛生物农业科技有限公司 |
具有部分或完全倍增基因组的普通小麦、植物或其部分,其杂种和产品,以及其生成和使用方法
|
CA2841551C
(en)
|
2011-07-18 |
2020-07-28 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
JP2014520567A
(ja)
|
2011-07-20 |
2014-08-25 |
カイイマ バイオ アグリテック リミテッド |
部分的多重ゲノムまたは完全多重ゲノムを有するトウモロコシ植物およびその使用
|
US20130030452A1
(en)
|
2011-07-27 |
2013-01-31 |
Health Corporation - Rambam |
Devices for surgical applications
|
HUE033746T2
(en)
|
2011-08-04 |
2018-01-29 |
Yeda Res & Dev |
MIR-135 and compositions thereof for the treatment of therapeutic conditions associated with serotonin
|
JP6063613B2
(ja)
|
2011-08-09 |
2017-01-18 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ベータ細胞の分化およびインスリン産生を促進するためのmiR−7のダウンレギュレーション
|
AR087524A1
(es)
|
2011-08-14 |
2014-03-26 |
Kaiima Bio Agritech Ltd |
Plantas de trigo durum que tienen un genoma parcial completamente multiplicado y sus usos
|
WO2013035070A1
(en)
|
2011-09-07 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Olfactory signature and odorant mixture having the same
|
WO2013035071A1
(en)
|
2011-09-08 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Novel risk biomarkers for lung cancer
|
CA2848121C
(en)
|
2011-09-08 |
2022-07-05 |
Yeda Research And Development Co. Ltd. |
Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP3382027A3
(en)
|
2011-09-13 |
2018-10-31 |
Monsanto Technology LLC |
Methods and compositions for weed control
|
CN103974967A
(zh)
|
2011-09-13 |
2014-08-06 |
孟山都技术公司 |
用于杂草控制的方法和组合物
|
WO2013040057A1
(en)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
MX342856B
(es)
|
2011-09-13 |
2016-10-13 |
Monsanto Technology Llc |
Metodos y composiciones para el control de malezas.
|
WO2013054320A1
(en)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
|
KR20140100939A
(ko)
|
2011-10-21 |
2014-08-18 |
오거렉스 라이프 사이언시스 코포레이션 |
시트룰린화된 14-3-3 유래 항원 및 류마티스 관절염 진단에서의 이의 용도
|
EP2771464B1
(en)
|
2011-10-27 |
2018-03-21 |
Yeda Research and Development Co. Ltd. |
Methods of treating cancer
|
US9422560B2
(en)
|
2011-11-03 |
2016-08-23 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for neuroprotection
|
US20140323549A1
(en)
|
2011-11-08 |
2014-10-30 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
US9736998B2
(en)
|
2011-11-23 |
2017-08-22 |
Danziger Dan Flower Farm |
Otomeria plants
|
US9617331B2
(en)
|
2011-11-27 |
2017-04-11 |
Yeda Research And Development Co. Ltd. |
Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
|
EP3034087B1
(en)
|
2011-12-08 |
2018-03-14 |
Yeda Research and Development Co. Ltd. |
Mammalian fetal pulmonary cells and therapeutic use of same
|
WO2013093921A1
(en)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Collagen coated synthetic polymer fibers
|
AU2012355990B2
(en)
|
2011-12-22 |
2017-10-12 |
Yeda Research And Development Co. Ltd. |
A combination therapy for a stable and long term engraftment
|
WO2013095729A1
(en)
|
2011-12-22 |
2013-06-27 |
Life Technologies Corporation |
Sequential lateral flow capillary device for analyte determination
|
AU2012359984A1
(en)
|
2011-12-28 |
2014-07-10 |
Kaiima Bio Agritech Ltd. |
Cultivated sorghum plant having a partially or fully multiplied genome and uses of same
|
WO2013098813A1
(en)
|
2012-01-01 |
2013-07-04 |
Qbi Enterprises Ltd. |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
US9603907B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Dry powder formulations of dNase I
|
WO2013118120A2
(en)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Isolated polynucleotides expressing or modulating micrornas or targets of same, transgenic plants comprising same and uses thereof in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant
|
IN2014MN01680A
(es)
|
2012-02-13 |
2015-07-03 |
Gamida Cell Ltd |
|
EP3326642B1
(en)
|
2012-02-14 |
2020-11-25 |
OPKO Biologics Ltd. |
Long-acting coagulation factors and uses thereof
|
EP2814838A1
(en)
|
2012-02-19 |
2014-12-24 |
Protalix Ltd. |
Oral unit dosage forms and uses of same for the treatment of gaucher disease
|
JP2015509366A
(ja)
|
2012-02-22 |
2015-03-30 |
ブレインステム バイオテック リミテッド |
神経幹細胞および運動ニューロンの生成
|
EP3401393B1
(en)
|
2012-02-22 |
2020-02-19 |
Exostem Biotec Ltd |
Micrornas for the generation of astrocytes
|
EP2833714A1
(en)
|
2012-03-01 |
2015-02-11 |
The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
CA2865486C
(en)
|
2012-03-07 |
2021-03-30 |
Yeda Research And Development Co. Ltd. |
Compositions for inhibition of quiescin sulfhydryl oxidase (qsox1) and uses of same
|
AU2013237087B2
(en)
|
2012-03-20 |
2017-07-20 |
Humabs Biomed Sa |
Antibodies that neutralize RSV, MPV and PVM and uses thereof
|
US9334308B2
(en)
|
2012-03-22 |
2016-05-10 |
Ramot At Tel-Aviv University Ltd. |
PLIF multimeric peptides and uses thereof
|
US9283272B2
(en)
|
2012-03-30 |
2016-03-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Targeting intracellular target-binding determinants with intracellular antibodies
|
CN104271749A
(zh)
|
2012-04-18 |
2015-01-07 |
雷蒙特亚特特拉维夫大学有限公司 |
用于递送核酸的脂化的糖胺聚糖颗粒
|
PE20142405A1
(es)
|
2012-04-19 |
2015-01-25 |
Opko Biolog Ltd |
Variantes de oxintomodulina de accion prolongada y metodos de produccion de las mismas
|
EP2841084B1
(en)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
|
ES2806945T3
(es)
|
2012-04-26 |
2021-02-19 |
Univ Chicago |
Antígenos de coagulasa estafilocócica y métodos para su uso
|
US9764008B2
(en)
|
2012-05-09 |
2017-09-19 |
Yeda Research And Development Co. Ltd. |
Variants of TACE pro-domain as TNF-A inhibitor and their medical use
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
US10240161B2
(en)
|
2012-05-24 |
2019-03-26 |
A.B. Seeds Ltd. |
Compositions and methods for silencing gene expression
|
BR112014029274B1
(pt)
|
2012-05-24 |
2022-02-15 |
Mountgate Innotech (Hk) Limited |
Anticorpo isolado, composição farmacêutica, uso do anticorpo, e, kit para tratar infecção rábica
|
US9731048B2
(en)
|
2012-06-03 |
2017-08-15 |
Ben-Gurion University Of The Negev Research And Development Authority |
Functionalized titanium binding peptides and implants coated with same
|
CA2875599C
(en)
|
2012-06-04 |
2020-08-18 |
Opko Biologics Ltd. |
Pegylated oxyntomodulin variants
|
WO2014006621A1
(en)
|
2012-07-03 |
2014-01-09 |
Nanospun Technologies Ltd. |
Methods and devices for adsorption and biodegradation of petroleum
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
DK2880155T3
(da)
|
2012-07-29 |
2019-07-15 |
Yeda Res & Dev |
Anvendelse af den reduktive glycinvej til generering af formatotrofiske og autotrofiske mikroorganismer
|
JP6340366B2
(ja)
|
2012-07-31 |
2018-06-06 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
運動ニューロン疾患を診断および処置する方法
|
DK2880151T3
(da)
|
2012-08-06 |
2020-08-17 |
Brainstorm Cell Therapeutics Ltd |
Fremgangsmåder til frembringelse af mesenkymale stemceller, som udskiller neurotrofiske faktorer
|
EP2698377A1
(en)
|
2012-08-17 |
2014-02-19 |
Laboratorios Del. Dr. Esteve, S.A. |
Enhanced rapid immunogen selection method for HIV gp120 variants
|
WO2014033723A1
(en)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Method of improving abiotic stress tolerance of plants and plants generated thereby
|
EP2895197B1
(en)
|
2012-09-12 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
WO2014052588A1
(en)
|
2012-09-27 |
2014-04-03 |
Research Development Foundation |
Attenuated chikungunya virus
|
EP2906954B1
(en)
|
2012-10-09 |
2018-04-11 |
Ramot at Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
CN104918639B
(zh)
|
2012-10-22 |
2018-01-26 |
萨拜格Rfa公司 |
用于将治疗剂递送到活细胞和细胞核中的系统
|
US20150266970A1
(en)
|
2012-10-24 |
2015-09-24 |
Yeda Research And Development Co. Ltd. |
Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
|
WO2014068553A1
(en)
|
2012-10-29 |
2014-05-08 |
Yeda Research And Development Co. Ltd. |
Aptamers, multimeric aptamers and uses thereof
|
US9808534B2
(en)
|
2012-11-20 |
2017-11-07 |
Opko Biologics Ltd. |
Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
|
MX2015004626A
(es)
|
2012-11-29 |
2015-07-14 |
Yeda Res & Dev |
Metodos para prevenir metastasis de tumor, tratar y pronosticar cancer e identificar agentes que son inhibidores putativos de metastasis.
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
BR112015015976A2
(pt)
|
2013-01-01 |
2018-04-10 |
A. B. Seeds Ltd. |
método para introduzir dsrna em sementes para modular a expressão genética
|
WO2014108854A1
(en)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
|
WO2014108850A2
(en)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
High throughput transcriptome analysis
|
CN104937412B
(zh)
|
2013-01-17 |
2018-05-25 |
诺威尔卢斯德克有限公司 |
用于鉴定患者特定驱动突变物的方法和系统
|
WO2014118785A1
(en)
|
2013-02-04 |
2014-08-07 |
Ramot At Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
AU2014224174B2
(en)
|
2013-03-06 |
2018-08-30 |
Hadasit Medical Research Services And Development Ltd. |
Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
|
WO2014136113A1
(en)
|
2013-03-06 |
2014-09-12 |
Protalix Ltd. |
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
|
EP2964254B1
(en)
|
2013-03-07 |
2019-09-18 |
University of Maryland, Baltimore |
Immunotherapeutic potential of modified lipooligosaccharides/lipid a
|
WO2014164797A2
(en)
|
2013-03-13 |
2014-10-09 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10609930B2
(en)
|
2013-03-13 |
2020-04-07 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP2976097B1
(en)
|
2013-03-21 |
2021-05-26 |
CollPlant Ltd. |
Compositions comprising collagen and prp for tissue regeneration and their production method
|
AU2014240733B2
(en)
|
2013-03-24 |
2018-11-22 |
Biolinerx Ltd. |
Methods of treating myeloid leukemia
|
BR112015026702A2
(pt)
|
2013-04-21 |
2018-02-06 |
Yeda Res And Developmente Co Ltd |
métodos de extermínio de células senescentes
|
WO2014174470A1
(en)
|
2013-04-23 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Isolated naive pluripotent stem cells and methods of generating same
|
EP2989119B1
(en)
|
2013-04-25 |
2018-03-21 |
Yeda Research and Development Co., Ltd. |
Use of inhibitory peptides for the treatment of inflammatory diseases
|
EP2999717B1
(en)
|
2013-05-21 |
2018-08-08 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
US10980730B2
(en)
|
2013-05-27 |
2021-04-20 |
Rakuto Bio Technologies Ltd. |
Enzymatic system-containing cosmetic compositions
|
ES2938044T3
(es)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Estructura a base de epiplón y sistema de suministro
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
RU2703498C2
(ru)
|
2013-07-19 |
2019-10-17 |
Монсанто Текнолоджи Ллс |
Композиции и способы борьбы с leptinotarsa
|
WO2015015489A1
(en)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Antibody for treating diabetes and autoimmune diseases
|
EP3039030B1
(en)
|
2013-08-29 |
2018-09-19 |
Yeda Research and Development Co. Ltd. |
Selective inhibitors of alpha2 isoform of na,k-atpase and use for reduction of intra-ocular pressure
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
US20160251410A1
(en)
|
2013-09-03 |
2016-09-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
WO2015033344A1
(en)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
|
WO2015037009A1
(en)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Isolated proteins capable of binding plexin-a4 and methods of producing and using same
|
ES2717446T3
(es)
|
2013-09-17 |
2019-06-21 |
Yeda Res & Dev |
Péptidos derivados de ERK y usos de los mismos
|
KR20160058822A
(ko)
|
2013-10-01 |
2016-05-25 |
카디마스템 리미티드 |
약물 스크리닝 및 근위축성 측삭 경화증 (als) 의 치료에서 사용하기 위한 인간 다능성 줄기 세포로부터의 성상세포의 유도 분화
|
HUE050933T2
(hu)
|
2013-10-02 |
2021-01-28 |
Medimmune Llc |
Semlegesítõ anti-influenza ellenanyagok és alkalmazásaik
|
AU2014338575B2
(en)
|
2013-10-21 |
2019-11-07 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
EP3060656A1
(en)
|
2013-10-24 |
2016-08-31 |
Yeda Research and Development Co., Ltd. |
Polynucleotides encoding brex system polypeptides and methods of using same
|
US20160243187A1
(en)
|
2013-10-31 |
2016-08-25 |
Biokine Therapeutics Ltd. |
Methods of treating acute myeloid leukemia with a flt3 mutation
|
UA120426C2
(uk)
|
2013-11-04 |
2019-12-10 |
Монсанто Текнолоджі Елелсі |
Композиція та спосіб для боротьби з членистоногими паразитами та зараженням шкідниками
|
EP3074044A2
(en)
|
2013-11-28 |
2016-10-05 |
Yeda Research and Development Co., Ltd. |
Synaptojanin-2 inhibitors and uses thereof
|
ES2754207T3
(es)
|
2013-11-28 |
2020-04-16 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Inhibidores de la ARN polimerasa I y usos de los mismos
|
US10053712B2
(en)
|
2013-12-10 |
2018-08-21 |
Yeda Research And Development Co. Ltd. |
Use of enzymes which catalyze pyruvate synthesis from formate and acetyl-CoA and bacteria expressing same
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
MX368629B
(es)
|
2014-01-15 |
2019-10-08 |
Monsanto Technology Llc |
Metodos y composiciones para el control de malezas utilizando polinucleotidos de 5-enolpiruvilshikimato-3-fosfato sintasa (epsps).
|
WO2015114633A1
(en)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same
|
JP2017506259A
(ja)
|
2014-02-03 |
2017-03-02 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッドYissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
幹細胞を枯渇させるためのカゼインキナーゼi阻害剤の使用
|
WO2015118537A2
(en)
|
2014-02-05 |
2015-08-13 |
Yeda Research And Development Co. Ltd. |
Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
CN106573976B
(zh)
|
2014-02-06 |
2020-05-05 |
耶达研究及发展有限公司 |
抗cd84抗体、包含所述抗体的组合物及其用途
|
WO2015118547A1
(en)
|
2014-02-10 |
2015-08-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
JP6628253B2
(ja)
|
2014-02-11 |
2020-01-08 |
ブレインストーム セル セラペウティクス リミテッド |
細胞の適性を判定する方法
|
US20170067894A1
(en)
|
2014-03-03 |
2017-03-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method and device for detection of pseudomonas aeruginosa
|
EP2923709A1
(en)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Multi-component-multistage malaria vaccine
|
WO2015153339A2
(en)
|
2014-04-01 |
2015-10-08 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
AU2015245963B2
(en)
|
2014-04-10 |
2019-02-28 |
Bonus Therapeutics Ltd. |
Bone repair compositions
|
EP4306659A3
(en)
|
2014-04-14 |
2024-03-27 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
A method and kit for determining the tissue or cell origin of dna
|
EP3132057B1
(en)
|
2014-04-17 |
2019-10-16 |
Yeda Research and Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
AU2015254886A1
(en)
|
2014-04-27 |
2016-11-03 |
Ccam Biotherapeutics Ltd. |
Humanized antibodies against CEACAM1
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
ES2870658T3
(es)
|
2014-04-28 |
2021-10-27 |
Yeda Res & Dev |
Respuesta del microbioma a agentes
|
SG11201609039QA
(en)
|
2014-05-04 |
2016-11-29 |
Forrest Innovations Ltd |
Compositions for mosquito control and uses of same
|
US10993990B2
(en)
|
2014-05-16 |
2021-05-04 |
Baylor Research Institute |
Methods and compositions for treating autoimmune and inflammatory conditions
|
US10294482B2
(en)
|
2014-05-22 |
2019-05-21 |
Yeda Research And Development Co. Ltd. |
Recombinant microorganisms capable of carbon fixation
|
WO2015186129A1
(en)
|
2014-06-02 |
2015-12-10 |
Technion Research & Development Foundation Limited. |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
WO2015186128A1
(en)
|
2014-06-02 |
2015-12-10 |
Kadimastem Ltd. |
Methods of inducing myelination and maturation of oligodendrocytes
|
CN106795515B
(zh)
|
2014-06-23 |
2021-06-08 |
孟山都技术公司 |
用于经由rna干扰调控基因表达的组合物和方法
|
WO2015198320A1
(en)
|
2014-06-24 |
2015-12-30 |
Insight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
CN106537148B
(zh)
|
2014-06-25 |
2019-10-11 |
泰尔哈绍梅尔医学研究基础设施和服务有限公司 |
癌症干细胞的鉴定及其用于诊断和治疗的用途
|
US11807857B2
(en)
|
2014-06-25 |
2023-11-07 |
Monsanto Technology Llc |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
EP3160448A4
(en)
|
2014-06-26 |
2018-11-14 |
Ramot at Tel-Aviv University Ltd. |
Liposomal formulations for delivery of nucleic acids
|
WO2016005985A2
(en)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming cells
|
EP3169343B1
(en)
|
2014-07-15 |
2020-03-25 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Isolated polypeptides of cd44 and uses thereof
|
US10294292B2
(en)
|
2014-07-15 |
2019-05-21 |
Medimmune, Llc |
Neutralizing anti-influenza B antibodies and uses thereof
|
CN107076727B
(zh)
|
2014-07-21 |
2019-11-01 |
诺威尔卢斯德克有限公司 |
用于确定患者特定突变的致癌指数的方法和系统
|
US10550439B2
(en)
|
2014-07-21 |
2020-02-04 |
Novellusdx Ltd. |
Methods for determining drug response of patient specific mutations
|
WO2016018887A1
(en)
|
2014-07-29 |
2016-02-04 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
EP3194572B1
(en)
|
2014-07-30 |
2023-10-25 |
Yeda Research and Development Co. Ltd. |
Media for culturing pluripotent stem cells
|
CA2954601C
(en)
|
2014-08-14 |
2023-04-18 |
Memed Diagnostics Ltd. |
Computational analysis of biological data using manifold and a hyperplane
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
WO2016038610A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (tki)
|
EP2992895A1
(en)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Three-component-multistage malaria vaccine
|
WO2016038609A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Anti-her3 antibodies and uses of same
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
US10174320B2
(en)
|
2014-09-21 |
2019-01-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Downregulating miR-132 for the treatment of lipid related disorders
|
US20170296650A1
(en)
|
2014-10-08 |
2017-10-19 |
Novartis Ag |
Combination of human cytomegalovirus neutralizing antibodies
|
DE102015220401B4
(de)
|
2014-10-20 |
2022-12-29 |
Gen-Probe Incorporated |
Erythrozyten-Lyselösung
|
US10570368B2
(en)
|
2014-11-13 |
2020-02-25 |
Enzootic Holdings Ltd. |
Functional sex-reversal of decapod crustacean females
|
WO2016075546A2
(en)
|
2014-11-14 |
2016-05-19 |
Antonio Lanzavecchia |
Antibodies that neutralize ebola virus and uses thereof
|
WO2016079736A2
(en)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Methods of treating diseases related to mitochondrial function
|
WO2016079731A2
(en)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Method of analyzing microbiome
|
CN114805558B
(zh)
|
2014-11-18 |
2023-12-29 |
胡默波斯生物医学公司 |
强力地中和狂犬病毒和其它狂犬病毒属病毒的抗体和其用途
|
EA038931B9
(ru)
|
2014-11-20 |
2022-02-18 |
Йиссум Рисерч Дивелопмент Компани Оф Зе Хебрю Юниверсити Оф Иерусалим Лтд. |
Композиции и способы получения полипептидов с модифицированным профилем гликозилирования в клетках растений
|
JP6860483B2
(ja)
|
2014-11-26 |
2021-04-14 |
テクノロジー イノベーション モメンタム ファンド(イスラエル)リミテッド パートナーシップTechnology Innovation Momentum Fund(israel)Limited Partnership |
細菌遺伝子の標的化削減
|
US10883111B2
(en)
|
2014-11-27 |
2021-01-05 |
Danziger Innovations Ltd. |
Nucleic acid constructs for genome editing
|
WO2016092555A2
(en)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2016103269A1
(en)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations of neural progenitor cells and methods of producing and using same
|
CA2972580A1
(en)
|
2014-12-30 |
2016-07-07 |
Cell Cure Neurosciences Ltd. |
Assessing retinal pigment epithelial cell populations
|
JP2018501281A
(ja)
|
2014-12-30 |
2018-01-18 |
セル キュア ニューロサイエンシズ リミテッド |
網膜疾患を治療する方法
|
ES2774456T3
(es)
|
2014-12-30 |
2020-07-21 |
Cell Cure Neurosciences Ltd |
Poblaciones de células del RPE y métodos de generación de las mismas
|
AU2016204793B2
(en)
|
2015-01-04 |
2021-12-16 |
Protalix Ltd. |
Modified DNase and uses thereof
|
WO2016116935A1
(en)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Use of rasa2 as a prognostic and therapeutic marker for melanoma
|
PL3256589T3
(pl)
|
2015-01-22 |
2022-02-21 |
Monsanto Technology Llc |
Kompozycje i sposoby kontrolowania leptinotarsa
|
WO2016135732A1
(en)
|
2015-02-26 |
2016-09-01 |
Yeda Research And Development Co. Ltd. |
Method of promoting hair growth
|
WO2016142948A1
(en)
|
2015-03-11 |
2016-09-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Decoy oligonucleotides for the treatment of diseases
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
ES2904573T3
(es)
|
2015-03-27 |
2022-04-05 |
Univ Southern California |
Terapia con células T dirigida a LHR para el tratamiento de tumores sólidos
|
WO2016157175A1
(en)
|
2015-03-27 |
2016-10-06 |
Yeda Research And Development Co. Ltd. |
Methods of treating motor neuron diseases
|
KR20170132293A
(ko)
|
2015-03-31 |
2017-12-01 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
글루타메이트 옥살로아세테이트 트랜스아미나제 1(got1) 제제와 이의 제조방법 및 용도
|
EP3277260B1
(en)
|
2015-04-01 |
2021-05-12 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Erodium crassifolium l'her plant extracts and uses thereof
|
JP2018515597A
(ja)
|
2015-04-07 |
2018-06-14 |
イーエルエイ ファーマ リミテッドEla Pharma Ltd |
カテプシンcおよび/またはcela1および/またはcela3aおよび/またはそれらに構造的に関連する酵素を特異的に標的とする細胞および/または組織壊死の処置および/または防止のための組成物
|
EP3081575A1
(en)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti-plasmodium parasite antibodies
|
CA2986202C
(en)
|
2015-04-27 |
2023-08-22 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Egr1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
CN108347945B
(zh)
|
2015-04-29 |
2021-03-23 |
以色列农业和农村发展部农业研究组织(范卡尼中心) |
抗植物致病组合物
|
WO2016174652A1
(en)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Chimeric antigen receptors and methods of their use
|
CN108026566A
(zh)
|
2015-05-04 |
2018-05-11 |
特拉维夫大学拉莫特有限公司 |
用于使dna片段化的方法和试剂盒
|
EP3294280A1
(en)
|
2015-05-11 |
2018-03-21 |
Yeda Research and Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
EP3298141A4
(en)
|
2015-05-17 |
2019-01-09 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
WO2016185481A2
(en)
|
2015-05-20 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
KR20180010237A
(ko)
|
2015-05-21 |
2018-01-30 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
건강 증진을 위한 박테리아 집단
|
WO2016193969A2
(en)
|
2015-05-29 |
2016-12-08 |
Opko Biologics Ltd. |
Pegylated oxyntomodulin variants
|
CN107667114B
(zh)
|
2015-06-01 |
2021-07-02 |
免疫医疗有限责任公司 |
中和抗流感结合分子及其用途
|
EP3302053B1
(en)
|
2015-06-02 |
2021-03-17 |
Monsanto Technology LLC |
Compositions and methods for delivery of a polynucleotide into a plant
|
WO2016196782A1
(en)
|
2015-06-03 |
2016-12-08 |
Monsanto Technology Llc |
Methods and compositions for introducing nucleic acids into plants
|
WO2016197064A1
(en)
|
2015-06-04 |
2016-12-08 |
Epstein Alan L |
Lym-1 and lym-2 targeted car cell immunotherapy
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
WO2016203476A1
(en)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and compositions for diagnosing and treating urothelial cancer
|
EP3310388B1
(en)
|
2015-06-18 |
2021-10-06 |
Yeda Research and Development Co., Ltd. |
Conditioning protocols and use of same for tissue regeneration
|
AU2016280867B2
(en)
|
2015-06-19 |
2020-02-27 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US20180179274A1
(en)
|
2015-06-26 |
2018-06-28 |
Institute For Research In Biomedicine |
Proteins comprising a mutated lair-1 fragment and uses thereof
|
WO2017009842A2
(en)
|
2015-07-16 |
2017-01-19 |
Biokine Therapeutics Ltd. |
Compositions and methods for treating cancer
|
WO2017009852A1
(en)
|
2015-07-16 |
2017-01-19 |
Yeda Research And Development Co. Ltd. |
Use of anti third party central memory t cells
|
EP3325494B1
(en)
|
2015-07-19 |
2020-12-30 |
Yeda Research and Development Co., Ltd. |
Selective inhibitors of alpha2-containing isoforms of na,k-atpase and use thereof for reducing intraocular pressure
|
CN107846936B
(zh)
|
2015-07-22 |
2021-06-01 |
芙图法尔马国际有限公司 |
蜜蜂可摄取组成物及使用其生产蜂蜜的方法与由此生产的蜂蜜
|
WO2017017686A1
(en)
|
2015-07-29 |
2017-02-02 |
Hadasit Medical Research Services And Development Ltd. |
Large scale production of retinal pigment epithelial cells
|
ES2965461T3
(es)
|
2015-08-03 |
2024-04-15 |
Biokine Therapeutics Ltd |
Inhibidor de CXCR4 para el tratamiento del cáncer
|
US20180237774A1
(en)
|
2015-08-04 |
2018-08-23 |
Yeda Research And Development Co. Ltd. |
Methods of screening for riboswitches and attenuators
|
CN108138145A
(zh)
|
2015-08-05 |
2018-06-08 |
细胞治疗神经科学有限公司 |
用于治疗视网膜疾病的光感受器的制备
|
EP4155391A1
(en)
|
2015-08-05 |
2023-03-29 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
EP3334449B1
(en)
|
2015-08-10 |
2021-09-29 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using cd24
|
EP3334831A1
(en)
|
2015-08-13 |
2018-06-20 |
Forrest Innovations Ltd. |
Formulations and compositions for delivery of nucleic acids to plant cells
|
WO2017033188A1
(en)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Algal oil and biofuel and methods of producing same
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
WO2017042814A1
(en)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Use of perforin positive immature dendritic cells in disease treatment
|
WO2017059878A1
(en)
|
2015-10-07 |
2017-04-13 |
Humabs Biomed Sa |
Antibodies that potently neutralize hepatitis b virus and uses thereof
|
WO2017072757A1
(en)
|
2015-10-25 |
2017-05-04 |
Yeda Research And Development Co. Ltd. |
Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
|
WO2017072763A1
(en)
|
2015-10-26 |
2017-05-04 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
CN109310648B
(zh)
|
2015-10-27 |
2022-06-03 |
杰伊制药公司 |
用于治疗癌症的包含大麻二酚和第二治疗剂的组合物
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
US20180303974A1
(en)
|
2015-11-03 |
2018-10-25 |
Ariel-University Research And Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
EP3374524A4
(en)
|
2015-11-11 |
2019-06-26 |
Ramot at Tel-Aviv University Ltd. |
PROCESS FOR DETECTION OF 5-HYDROXYMETHYLCYTOSINE AND FOR DIAGNOSIS OF CANCER
|
IL293289B2
(en)
|
2015-11-30 |
2024-04-01 |
Kadimastem Ltd |
Methods for differentiation and purification of pancreatic endocrine cells
|
EP3176183A1
(en)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki)
|
EP4059507A1
(en)
|
2015-12-16 |
2022-09-21 |
Ramot at Tel-Aviv University Ltd. |
Particles comprising decellularized omentum
|
US10561706B2
(en)
|
2015-12-28 |
2020-02-18 |
B. G. Negev Technologies And Applications |
Isolated polypeptide and compositions comprising same
|
CA3009127A1
(en)
|
2016-01-06 |
2017-07-13 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating malignant, autoimmune and inflammatory diseases
|
US20190178888A1
(en)
|
2016-01-11 |
2019-06-13 |
Technion Research & Development Foundation Limited |
Methods of determining prognosis of sepsis and treating same
|
SG11201805001UA
(en)
|
2016-01-13 |
2018-07-30 |
Medimmune Llc |
Method of treating influenza a
|
WO2017125931A1
(en)
|
2016-01-21 |
2017-07-27 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Parthenocarpic plants and methods of producing same
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
US11261433B2
(en)
|
2016-01-31 |
2022-03-01 |
Hadasit Medical Research Services And Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
WO2017134671A1
(en)
|
2016-02-04 |
2017-08-10 |
Yeda Research And Development Co. Ltd. |
Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant p53
|
US20190046497A1
(en)
|
2016-02-14 |
2019-02-14 |
Yeda Research And Development Co., Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
ES2771223T3
(es)
|
2016-02-14 |
2020-07-06 |
Yeda Res & Dev |
Diagnóstico, predicción y tratamiento de la obesidad recidivante basados en el microbioma
|
EP3416488A1
(en)
|
2016-02-16 |
2018-12-26 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Non-protein phenylalanine analogues for inhibiting cyanobacteria and plant growth
|
JP2019511919A
(ja)
|
2016-02-23 |
2019-05-09 |
ブローディ,チャヤ |
がん幹細胞の作製およびその使用
|
KR20180133399A
(ko)
|
2016-03-01 |
2018-12-14 |
이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. |
인간 폴리오바이러스 수용체(pvr)에 특이적인 항체
|
CN114959084A
(zh)
|
2016-03-03 |
2022-08-30 |
米密德诊断学有限公司 |
分析rna用于诊断感染类型
|
WO2017153982A1
(en)
|
2016-03-06 |
2017-09-14 |
Yeda Research And Development Co. Ltd. |
Method for modulating myelination
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
WO2017189746A1
(en)
|
2016-04-27 |
2017-11-02 |
Gen-Probe Incorporated |
Blood cell lysis reagent
|
WO2017203520A1
(en)
|
2016-05-22 |
2017-11-30 |
Yeda Research And Development Co. Ltd. |
Methods of using pulmonary cells for transplantation and induction of tolerance
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
WO2017208247A1
(en)
|
2016-06-02 |
2017-12-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
US11820833B2
(en)
|
2016-06-05 |
2023-11-21 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Peptides that inhibit binding of EPCR to its ligand to treat inflammation
|
EP3468610A1
(en)
|
2016-06-09 |
2019-04-17 |
OPKO Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
WO2017221225A1
(en)
|
2016-06-19 |
2017-12-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Screening for chemotherapy resistance in human haploid cells
|
AU2017289879B2
(en)
|
2016-06-27 |
2023-04-20 |
Yeda Research And Development Co. Ltd. |
Veto cells generated from memory T cells
|
US11340223B2
(en)
|
2016-07-10 |
2022-05-24 |
Memed Diagnostics Ltd. |
Early diagnosis of infections
|
WO2018011795A1
(en)
|
2016-07-10 |
2018-01-18 |
Memed Diagnostics Ltd. |
Protein signatures for distinguishing between bacterial and viral infections
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
CN109714962A
(zh)
|
2016-07-11 |
2019-05-03 |
耶路撒冷希伯来大学的益生研究开发有限公司 |
用于在体外培养细胞的系统和方法
|
MX2019000554A
(es)
|
2016-07-11 |
2019-09-19 |
Opko Biologics Ltd |
Factor vii de coagulación de acción prolongada y métodos para producir el mismo.
|
WO2018011804A1
(en)
|
2016-07-11 |
2018-01-18 |
Bonus Therapeutics Ltd. |
Cell compositions for tissue regeneration
|
WO2018010789A1
(en)
|
2016-07-13 |
2018-01-18 |
Humabs Biomed Sa |
Novel antibodies specifically binding to zika virus epitopes and uses thereof
|
WO2018020489A1
(en)
|
2016-07-24 |
2018-02-01 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
US10982252B2
(en)
|
2016-08-08 |
2021-04-20 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Bacterial systems for analyzing ubiquitylated polypeptides
|
US20190180846A1
(en)
|
2016-08-10 |
2019-06-13 |
Memed Diagnostics Ltd. |
System and method for analysis of biological data
|
EP3497239A4
(en)
|
2016-08-10 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
METHYLATION STATUS ANALYSIS AND COPY NUMBER
|
CN109843305B
(zh)
|
2016-08-14 |
2023-03-10 |
雷蒙特亚特特拉维夫大学有限公司 |
治疗神经障碍的间充质细胞来源的外泌体
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
EP3510047A1
(en)
|
2016-09-07 |
2019-07-17 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Anti-nkp46 antibodies and therapeutic use of same
|
US11485971B2
(en)
|
2016-09-14 |
2022-11-01 |
Yeda Research And Development Co. Ltd. |
CRISP-seq, an integrated method for massively parallel single cell RNA-seq and CRISPR pooled screens
|
EP3519833A4
(en)
|
2016-09-29 |
2020-06-03 |
MeMed Diagnostics Ltd. |
PROGNOSTIC AND TREATMENT METHODS
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
US10662226B2
(en)
|
2016-10-28 |
2020-05-26 |
The Regents of the University of Caiifomia |
Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
|
WO2018087759A1
(en)
|
2016-11-10 |
2018-05-17 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
JP2019535298A
(ja)
|
2016-11-28 |
2019-12-12 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
単離ポリヌクレオチドおよびポリペプチドおよび関心のある発現産物を発現させるためにそれらを使用する方法
|
EP3548015A1
(en)
|
2016-11-30 |
2019-10-09 |
Yeda Research and Development Co. Ltd. |
Methods of treating liver toxicity and disorders
|
EP3548106B1
(en)
|
2016-12-01 |
2023-01-04 |
Ramot at Tel-Aviv University Ltd. |
Combined treatment for nerve injuries
|
EP3571295A1
(en)
|
2017-01-18 |
2019-11-27 |
Yeda Research and Development Co. Ltd |
Genetically modified veto cells and use of same in immunotherapy
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
WO2018167780A1
(en)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Methods of prognosing and treating cancer
|
EP3596469A1
(en)
|
2017-03-12 |
2020-01-22 |
Yeda Research and Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
CN118021843A
(zh)
|
2017-03-16 |
2024-05-14 |
谱系细胞疗法公司 |
用于测量视网膜疾病疗法的疗效的方法
|
EP4317971A3
(en)
|
2017-04-05 |
2024-04-17 |
Yeda Research and Development Co. Ltd |
Ex-vivo culture system and methods of using same
|
JP7278259B2
(ja)
|
2017-04-19 |
2023-05-19 |
インスティテュート・フォー・リサーチ・イン・バイオメディシン |
ワクチン及び標的としてのプラスモジウムスポロゾイトnpdpペプチド、新規マラリアワクチン、及びそれに結合する抗体
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
WO2018207184A2
(en)
|
2017-05-10 |
2018-11-15 |
Ariel Scientific Innovations Ltd. |
Methods of purifying antibodies
|
ES2939298T3
(es)
|
2017-05-21 |
2023-04-20 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
Combinación de marcadores para el diagnóstico del cáncer
|
US20200172604A1
(en)
|
2017-05-23 |
2020-06-04 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
US20200109408A1
(en)
|
2017-05-31 |
2020-04-09 |
Tropic Biosciences UK Limited |
Methods of selecting cells comprising genome editing events
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
WO2018229764A1
(en)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Treatment of advanced or progressive multiple sclerosis
|
EP3652343A1
(en)
|
2017-07-13 |
2020-05-20 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Dual-probe digital droplet pcr strategy for specific detection of tissue-specific circulating dna molecules
|
EP3652342A1
(en)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Detecting tissue-specific dna
|
US20200340057A1
(en)
|
2017-07-13 |
2020-10-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Dna targets as tissue-specific methylation markers
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
WO2019038771A1
(en)
|
2017-08-23 |
2019-02-28 |
Technion Research & Development Foundation Limited |
COMPOSITIONS AND METHODS FOR ENHANCING ALCOHOL TOLERANCE IN YEAST
|
WO2019042555A1
(en)
|
2017-08-31 |
2019-03-07 |
Humabs Biomed Sa |
MULTISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF
|
JP7462553B2
(ja)
|
2017-09-19 |
2024-04-05 |
トロピック バイオサイエンシーズ ユーケー リミテッド |
遺伝子発現をサイレンシングするための植物非コードrna分子の特異性の改変
|
AU2018364630A1
(en)
|
2017-11-09 |
2020-05-21 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
IL274979B1
(en)
|
2017-11-29 |
2024-03-01 |
Univ Ramot |
Methods for the prevention and treatment of neurogenic seizures
|
BR112020010830A2
(pt)
|
2017-11-29 |
2020-11-10 |
Weedout Ltd. |
composições, kits e métodos para controlar erva daninha do gênero amaranthus
|
WO2019106680A1
(en)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Treatment of an ischemic heart disease
|
WO2019116376A1
(en)
|
2017-12-17 |
2019-06-20 |
Yeda Research And Development Co. Ltd. |
Cop9 signalosome (csn) complex modulators and uses thereof
|
EP3731965A1
(en)
|
2017-12-28 |
2020-11-04 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Method to reproduce circadian rhythms on a microfluidic chip
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
WO2019155465A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
|
WO2019155459A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Inhibitors of the 20s proteasome
|
US11571433B2
(en)
|
2018-02-23 |
2023-02-07 |
Carmel Haifa University Economic Corporation Ltd. |
Methods for treating memory impairment and cognitive dysfunction
|
US20200408761A1
(en)
|
2018-02-28 |
2020-12-31 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
EP3765034A1
(en)
|
2018-03-12 |
2021-01-20 |
Yeda Research and Development Co. Ltd |
Treatment of a heart disease
|
WO2019183500A1
(en)
|
2018-03-23 |
2019-09-26 |
Hung Chiung Yu |
Coccidioides antigens and methods of their use
|
CN112236131A
(zh)
|
2018-03-29 |
2021-01-15 |
技术研究及发展基金有限公司 |
包含pten抑制剂的囊泡及其用途
|
EP3774047A1
(en)
|
2018-03-29 |
2021-02-17 |
Yeda Research and Development Co. Ltd |
Use of electric field gradients to control gene expression
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
WO2019220441A1
(en)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions and methods for treating cancer resistant to an anti-cancer agent
|
CA3099383A1
(en)
|
2018-05-27 |
2019-12-05 |
Biolinerx Ltd. |
Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
US20210337753A1
(en)
|
2018-06-07 |
2021-11-04 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Methods of regenerating and transforming cannabis
|
CN112424365A
(zh)
|
2018-06-07 |
2021-02-26 |
以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心 |
核酸构建体及其使用方法
|
EP3810636A1
(en)
|
2018-06-25 |
2021-04-28 |
Yeda Research and Development Co. Ltd |
Systems and methods for increasing efficiency of genome editing
|
WO2020008412A1
(en)
|
2018-07-04 |
2020-01-09 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
WO2020012467A2
(en)
|
2018-07-08 |
2020-01-16 |
Yeda Research And Development Co. Ltd. |
Person-specific assessment of probiotics responsiveness
|
SG11202012773QA
(en)
|
2018-07-11 |
2021-01-28 |
Immunity Pharma Ltd |
Peptide compounds and therapeutic uses of same
|
MX2021000263A
(es)
|
2018-07-11 |
2021-05-12 |
Kahr Medical Ltd |
Proteina de fusion variante sirpalfa-4-1bbl y procedimientos de uso de la misma.
|
CN112823208A
(zh)
|
2018-07-31 |
2021-05-18 |
科弗朗有限公司 |
烟草转基因事件及用于检测与使用烟草转基因事件的方法
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
WO2020041360A1
(en)
|
2018-08-21 |
2020-02-27 |
Quidel Corporation |
Dbpa antibodies and uses thereof
|
EP3841201A1
(en)
|
2018-08-24 |
2021-06-30 |
Yeda Research and Development Co. Ltd |
Methods of modulating m2 macrophage polarization and use of same in therapy
|
CN113038951B
(zh)
|
2018-09-20 |
2024-04-30 |
耶达研究及发展有限公司 |
治疗肌萎缩侧索硬化的方法
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
SG11202106483WA
(en)
|
2018-12-19 |
2021-07-29 |
Humabs Biomed Sa |
Antibodies that neutralize hepatitis b virus and uses thereof
|
WO2020152686A1
(en)
|
2019-01-23 |
2020-07-30 |
Yeda Research And Development Co. Ltd. |
Culture media for pluripotent stem cells
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
WO2020170239A1
(en)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of generating organoids for high throughput screening of drugs
|
WO2020170240A1
(en)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reduction drug-induced nephrotoxicity
|
CN113692225B
(zh)
|
2019-03-05 |
2023-04-18 |
以色列农业和农村发展部农业研究组织(范卡尼中心) |
经基因组编辑的鸟类
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020193718A1
(en)
|
2019-03-27 |
2020-10-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Recombinant proteins with cd40 activating properties
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
WO2020202142A2
(en)
|
2019-03-31 |
2020-10-08 |
Yeda Research And Development Co. Ltd. |
Anti-viral and anti-tumoral compounds
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
US20220220559A1
(en)
|
2019-05-13 |
2022-07-14 |
Yeda Research And Development Co. Ltd. |
Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
JP2022533745A
(ja)
|
2019-05-22 |
2022-07-25 |
ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド |
ヒト多能性細胞を培養する方法
|
US20220251179A1
(en)
|
2019-05-28 |
2022-08-11 |
Shanghaitech University |
Composition and methods to treat ectodermal dysplasia 2, clouston type
|
US20220233477A1
(en)
|
2019-06-12 |
2022-07-28 |
Hadasit Medical Research Services And Development Ltd. |
Methods of generating oligodendrocytes
|
WO2020255124A1
(en)
|
2019-06-16 |
2020-12-24 |
Yeda Research And Development Co. Ltd. |
Method for stabilizing intracellular rna
|
WO2020261281A1
(en)
|
2019-06-27 |
2020-12-30 |
Ramot At Tel-Aviv University Ltd. |
Semaphorin 3a antibodies and uses thereof
|
CN114938647A
(zh)
|
2019-07-04 |
2022-08-23 |
乌科公司 |
去表位的α-麦醇溶蛋白及其在乳糜泻和麸质敏感性管理中的用途
|
US20220267409A1
(en)
|
2019-07-11 |
2022-08-25 |
Kahr Medical Ltd. |
Heterodimers and methods of use thereof
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
US20220281960A1
(en)
|
2019-07-16 |
2022-09-08 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
EP4004548A1
(en)
|
2019-07-29 |
2022-06-01 |
Yeda Research and Development Co. Ltd |
Methods of treating and diagnosing lung cancer
|
CA3148950A1
(en)
|
2019-07-30 |
2021-02-04 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (A.R.O.), Volcani Center |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
WO2021028909A1
(en)
|
2019-08-12 |
2021-02-18 |
Yeda Research And Development Co. Ltd. |
Dna repair blood test for predicting response of lung cancer patients to immunotherapy
|
US20240140988A1
(en)
|
2019-08-22 |
2024-05-02 |
Ariel Scientific Innovations Ltd. |
Scaled-up methods for purifying antibodies
|
WO2021038569A1
(en)
|
2019-08-27 |
2021-03-04 |
Yeda Research And Development Co. Ltd. |
Treatment of bacterial vaginosis
|
CN114630680A
(zh)
|
2019-08-29 |
2022-06-14 |
维尔生物科技有限公司 |
用于治疗乙型肝炎病毒感染的抗体组合物和方法
|
WO2021048852A1
(en)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating breast cancer
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
US20240117386A1
(en)
|
2019-10-31 |
2024-04-11 |
Yeda Research And Development Co. Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
IL292879A
(en)
|
2019-11-11 |
2022-07-01 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanoantibodies for insect control and their uses
|
US20230022576A1
(en)
|
2019-11-19 |
2023-01-26 |
Protalix Ltd. |
Removal of constructs from transformed cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
CN114787181A
(zh)
|
2019-11-21 |
2022-07-22 |
Inserm(法国国家健康医学研究院) |
用抗pd-1/il-15免疫细胞因子靶向pd-1的新型免疫疗法
|
CN112898414B
(zh)
|
2019-12-04 |
2024-05-10 |
珠海泰诺麦博制药股份有限公司 |
抗人巨细胞病毒抗体及其用途
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
EP4077731A1
(en)
|
2019-12-22 |
2022-10-26 |
Yeda Research and Development Co. Ltd |
Diagnosis of frontotemporal dementia
|
WO2021137231A1
(en)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
WO2021137230A1
(en)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
IL272074A
(en)
|
2020-01-15 |
2021-07-29 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(en)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Methods of analyzing cell membranes
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
EP4096647A1
(en)
|
2020-01-30 |
2022-12-07 |
Yeda Research and Development Co. Ltd |
Treating acute liver disease with tlr-mik inhibitors
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
WO2021152586A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Methods of analyzing microbiome, immunoglobulin profile and physiological state
|
WO2021156878A2
(en)
|
2020-02-09 |
2021-08-12 |
Nlc Pharma Ltd |
Rapid detection test for sars-cov-2
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
EP4110823A1
(en)
|
2020-02-26 |
2023-01-04 |
A2 Biotherapeutics, Inc. |
Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
|
WO2021178637A1
(en)
|
2020-03-05 |
2021-09-10 |
Iowa State University Research Foundation, Inc. |
IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SARS-CoV-2
|
US20230127559A1
(en)
|
2020-03-16 |
2023-04-27 |
Yeda Research And Development Co. Ltd. |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with mutant p53 protein
|
AU2021245409A1
(en)
|
2020-03-29 |
2022-11-24 |
Yeda Research And Development Co. Ltd. |
Variants of beta-glucocerebrosidase for use in treating Gaucher Disease
|
IL296698A
(en)
|
2020-03-31 |
2022-11-01 |
Biomuse Ltd |
Bacteria for the prevention and treatment of smoking damage to the lungs
|
WO2021205444A1
(en)
|
2020-04-06 |
2021-10-14 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing cancer and predicting responsiveness to therapy
|
WO2021205459A1
(en)
|
2020-04-07 |
2021-10-14 |
Ramot At Tel-Aviv University Ltd. |
Cannabidiol-containing compositions and uses thereof
|
AU2021255132A1
(en)
|
2020-04-13 |
2022-12-08 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type P53 protein for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
WO2021229577A1
(en)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagen as a delivery tool for metal-based anti-viral agents
|
WO2021228836A1
(en)
|
2020-05-13 |
2021-11-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Recombinant proteins with ox40 activating properties
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
WO2021260675A1
(en)
|
2020-06-24 |
2021-12-30 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
WO2021262840A1
(en)
|
2020-06-24 |
2021-12-30 |
Vir Biotechnology, Inc. |
Engineered hepatitis b virus neutralizing antibodies and uses thereof
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
EP4199703A1
(en)
|
2020-08-18 |
2023-06-28 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
WO2022064494A2
(en)
|
2020-09-23 |
2022-03-31 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating coronaviral infections
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
US20230374447A1
(en)
|
2020-10-05 |
2023-11-23 |
Protalix Ltd. |
Dicer-like knock-out plant cells
|
CN116635056A
(zh)
|
2020-10-07 |
2023-08-22 |
波塔力克斯有限公司 |
长效脱氧核糖核酸酶
|
WO2022079719A1
(en)
|
2020-10-15 |
2022-04-21 |
Yeda Research And Development Co. Ltd. |
Method of treating myeloid malignancies
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
KR20230107296A
(ko)
|
2020-11-09 |
2023-07-14 |
1이 테라퓨틱스 엘티디. |
촉매 서열에 기반한 박테리아 감염을 치료 또는 예방하는 방법
|
JP2023550979A
(ja)
|
2020-11-26 |
2023-12-06 |
ウッコ インコーポレイテッド |
改変された高分子量グルテニンサブユニット及びその使用
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
KR20230133859A
(ko)
|
2020-12-28 |
2023-09-19 |
1이 테라퓨틱스 엘티디. |
p21 mRNA 표적화 DNA자임
|
IL304047A
(en)
|
2020-12-28 |
2023-08-01 |
1E Therapeutics Ltd |
Silencing target sites in the p21 mRNA sequence
|
AU2022206415A1
(en)
|
2021-01-10 |
2023-08-17 |
Supermeat The Essence Of Meat Ltd. |
Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
|
US20240083843A1
(en)
|
2021-01-14 |
2024-03-14 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
WO2022164805A1
(en)
|
2021-01-26 |
2022-08-04 |
Vir Biotechnology, Inc. |
Compositions and methods for treating hepatitis b virus infection
|
CA3208982A1
(en)
|
2021-02-18 |
2022-08-25 |
Ravid STRAUSSMAN |
Method of generating vaccines
|
WO2022175951A1
(en)
|
2021-02-18 |
2022-08-25 |
Yeda Research And Development Co. Ltd. |
Genetically modified bacteria for generating vaccines
|
JP2024509973A
(ja)
|
2021-03-10 |
2024-03-05 |
マビュロン アーゲー |
Tdp-43に対する抗体およびその使用方法
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
AU2022247325A1
(en)
|
2021-03-30 |
2023-10-05 |
Biomx Ltd. |
Pseudomonas bacteriophage and uses thereof
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
EP4337764A1
(en)
|
2021-05-12 |
2024-03-20 |
Biomx Ltd. |
Staphylococcus bacteriophage and uses thereof
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
WO2022259242A1
(en)
|
2021-06-06 |
2022-12-15 |
Yeda Research And Development Co. Ltd. |
Combined treatment for cancer
|
WO2022264132A1
(en)
|
2021-06-13 |
2022-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming human cells
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
WO2022264076A1
(en)
|
2021-06-16 |
2022-12-22 |
Seedx Technologies Inc. |
Methods of sorting matthiola seeds
|
EP4362662A1
(en)
|
2021-07-02 |
2024-05-08 |
Tropic Biosciences UK Limited |
Delay or prevention of browning in banana fruit
|
CN117980470A
(zh)
|
2021-07-18 |
2024-05-03 |
盖米达细胞有限公司 |
治疗性nk细胞群
|
WO2023002492A1
(en)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Codon optimization of nucleic acids
|
WO2023012584A2
(en)
|
2021-08-03 |
2023-02-09 |
Genicity Limited |
Engineered tcr complex and methods of using same
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
AU2022325816A1
(en)
|
2021-08-10 |
2024-03-21 |
Gamida-Cell Ltd. |
Engineered nk cells, methods of their production and uses thereof
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
WO2023105526A1
(en)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Multipotent lung progenitor cells for lung regeneration
|
WO2023144779A1
(en)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Coronavirus antigen variants
|
WO2023209708A1
(en)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions for altering cyclic adp-ribose secondary messenger signalling
|
WO2023242155A1
(en)
|
2022-06-14 |
2023-12-21 |
Janssen Vaccines & Prevention B.V. |
Compositions and methods for the diagnosis of hiv infection
|